Alzheimer’s disease, strict definition

G6_AD_STRICT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.0, F00.00, F00.00G30.0, F00.1, F00.10, F00.10G30.1, G30.0, G30.0+F00.00, G30.1, G30.1+F00.10 Hospital discharge: ICD-9 — 3310 Hospital discharge: ICD-8 — 29010 Cause of death: ICD-10 — F00.0, F00.00, F00.00G30.0, F00.1, F00.10, F00.10G30.1, G30.0, G30.0+F00.00, G30.1, G30.1+F00.10 Cause of death: ICD-9 — 3310 Cause of death: ICD-8 — 29010 KELA reimbursements: KELA codes — 307 KELA reimbursements: ICD-10 — F00.0, F00.00, F00.00G30.0, F00.1, F00.10, F00.10G30.1, G30.0, G30.0+F00.00, G30.1, G30.1+F00.10 3 out of 7 registries used, show all original rules.	12926
4. Check minimum number of events None	12926
5. Include endpoints None	12926
6. Filter based on genotype QC (FinnGen only)	12545

Control definitions (FinnGen only)

Control exclude: G6_ALZHEIMER

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	G6_AD_STRICT
CONTROL_EXCLUDE	G6_ALZHEIMER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G30[01]\|F00[01]
HD_ICD_9	3310
HD_ICD_8	29010
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G30[01]\|F00[01]
COD_ICD_9	3310
COD_ICD_8	29010
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	307
KELA_REIMB_ICD	G30[01]\|F00[01]
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease, strict definition based on the number of shared cases.

Similar with more cases:

Unspecific neurodegenerative disorder

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12545	6182	6363
Unadjusted period prevalence (%)	2.56	2.19	2.92
Median age at first event (years)	80.17	80.09	80.25

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12161: Matched controls
100154

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TAB00

NOMESCO Finland

Lumbar puncture

5.4

317.6

702

1130

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

102.0

316.3

195

F06.7

ICD-10 Finland

Mild cognitive disorder

4.6

307.7

1046

1988

N06DX01

ATC

memantine; oral

64.0

307.7

7859

2781

F0019, G301,

ICD-10 Finland

6827.7

307.7

785

R41.3

ICD-10 Finland

Other amnesia

6.1

307.7

1119

1628

G30.0

ICD-10 Finland

Alzheimer disease with early onset

637.1

307.7

1187

WYA20

NOMESCO Finland

Home visit

6.6

307.7

675

878

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.5

307.7

1344

3419

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

44.3

307.7

451

G30

ICD-10 Finland

Alzheimer disease

61.2

307.7

1004

147

F009, G309,

ICD-10 Finland

1573.3

307.7

355

G30.1

ICD-10 Finland

Alzheimer disease with late onset

282.0

307.7

9360

1173

N06DA02

ATC

donepezil; oral

45.9

307.7

6176

2204

N05AX08

ATC

risperidone; systemic

10.1

307.7

3700

4169

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

110.3

307.7

4856

600

SPAT1053

SPAT

Memory test

3.3

307.7

4422

14595

G30.8

ICD-10 Finland

Other Alzheimer disease

34.2

307.7

1222

326

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

9.9

307.7

787

694

F05.1

ICD-10 Finland

Delirium superimposed on dementia

12.0

307.7

386

273

N06DA04

ATC

galantamine; oral

15.5

307.7

1592

964

N05BA04

ATC

oxazepam; oral

2.3

307.7

3867

16998

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.9

307.7

3846

6291

F03

ICD-10 Finland

Unspecified dementia

6.1

307.7

2291

3680

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

199.9

307.7

238

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

189.0

307.7

3515

215

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

79.2

307.7

4217

667

P20

ICPC

Memory disturbance

7.0

307.7

5928

11976

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

129.0

307.7

1462

106

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

227.9

307.7

753

A28

ICPC

Limited function/disability NOS

2.7

307.7

4427

17697

P70

ICPC

Dementia

17.1

307.7

1722

959

N06DA03

ATC

rivastigmine; oral, transdermal

26.9

307.7

3813

1671

N05AH04

ATC

quetiapine; oral

4.3

307.7

2862

6726

F001, G301,

ICD-10 Finland

131.4

286.7

173

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

15.3

282.9

280

154

R53

ICD-10 Finland

Malaise and fatigue

2.1

276.3

3753

17505

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

130.1

258.3

156

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

252.7

5064

26939

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

252.6

2028

7561

F0009, G300,

ICD-10 Finland

+∞

243.3

251

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

102.1

238.4

147

SPAT1216

SPAT

Assessment of functional ability

2.1

237.0

3091

14061

N03AG01

ATC

valproic acid; systemic, rectal

3.7

234.4

831

1948

N06AX11

ATC

mirtazapine; oral

1.9

225.7

4178

21439

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.2

221.9

497

807

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.1

220.9

2926

13338

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.5

218.3

1634

5867

N05AH03

ATC

olanzapine; systemic

4.0

215.4

684

1480

SPAT1234

SPAT

Support of social functional capacity

2.8

214.7

1241

3912

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.9

202.0

1102

3363

R41.0

ICD-10 Finland

Disorientation, unspecified

3.3

200.8

848

2226

XA800

NOMESCO Finland

Neuropsychological investigation

4.7

190.1

487

889

F00

ICD-10 Finland

Dementia in Alzheimer disease

15.6

178.1

174

N06AB10

ATC

escitalopram; oral

2.2

175.5

1752

7093

Z75.5

ICD-10 Finland

Holiday relief care

5.5

170.3

360

553

N06AX26

ATC

vortioxetine; oral

3.3

164.5

684

1774

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

161.0

3440

18069

F0014, G301,

ICD-10 Finland

353.4

157.2

170

N05AD01

ATC

haloperidol; systemic

3.2

157.1

700

1894

N05BA06

ATC

lorazepam; systemic, sublingual

2.7

149.9

932

3032

N02AA05

ATC

oxycodone; systemic

1.8

146.2

3005

15528

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

60.0

142.7

SPAT1254

SPAT

Administration of medicine

1.8

139.7

2455

12071

A04

ICPC

Weakness/tiredness general

1.9

132.6

2183

10495

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

131.9

4477

26348

AA1AD

NOMESCO Finland

CT of head and brain

1.6

128.8

4094

23668

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

122.3

2601

13473

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

121.0

874

3050

S72.0

ICD-10 Finland

Fracture of neck of femur

2.3

119.0

1024

3864

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

4.1

118.9

352

720

N02BE01

ATC

paracetamol; systemic, rectal

1.8

116.0

10067

73234

A06AD11

ATC

lactulose; oral

1.7

115.8

2822

15147

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

105.4

1834

23959

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.9

102.1

1410

6355

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

101.6

2224

11538

L28

ICPC

Limited function/disability (L)

1.6

100.2

2909

16240

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.5

99.9

676

2283

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.6

95.0

339

793

N06AB04

ATC

citalopram; systemic

1.7

92.6

2335

12545

F0029, G308,

ICD-10 Finland

+∞

90.9

U04

ICPC

Incontinence urine

2.1

89.6

946

3862

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

88.9

2313

12509

R55

ICD-10 Finland

Syncope and collapse

1.7

88.3

1801

9125

S01.0

ICD-10 Finland

Open wound of scalp

1.9

86.0

1151

5116

Z01.9

ICD-10 Finland

Special examination, unspecified

2.3

85.4

742

2800

130

Kela drug reimbursment

Malignant tumour

0.3

85.3

284

7000

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

85.1

SPAT1360

SPAT

Extensive global examination

2.0

82.8

1039

4515

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

81.9

1401

18631

F21, ,

ICPC

4.0

77.9

239

502

S06.0

ICD-10 Finland

Concussion

1.8

77.9

1258

5936

AXX01, ,

SPAT

2.5

77.4

532

1807

F0011, G301,

ICD-10 Finland

178.3

76.9

SPAT1101

SPAT

Orthostatic test

2.0

75.4

861

3613

N07AA05, ,

ATC

620.6

70.7

N05AD03

ATC

melperone; systemic

3.3

70.3

286

729

N06AB06

ATC

sertraline; oral

2.0

68.5

834

3579

F05.9

ICD-10 Finland

Delirium, unspecified

2.6

68.5

444

1466

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

68.0

779

3270

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.3

67.6

185

356

SPAT1252

SPAT

Overall medication plan or its review

1.8

67.1

1070

5017

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

66.5

1664

8847

W19

ICD-10 Finland

Unspecified fall

1.7

65.4

1283

6393

Z29

ICPC

Social problem NOS

3.1

65.1

295

803

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

63.1

611

9727

J01CA08

ATC

pivmecillinam; oral

1.4

62.4

4116

26699

H02AB02

ATC

dexamethasone; systemic

0.4

61.2

324

6485

A29

ICPC

General symptom/complaint other

1.6

58.8

1611

8737

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

57.9

773

3418

N30.0

ICD-10 Finland

Acute cystitis

1.5

56.8

1938

11040

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

80.5

56.8

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.8

56.4

1010

4894

SPAT1153

SPAT

Removal of sutures

0.7

56.4

2099

23739

S70.0

ICD-10 Finland

Contusion of hip

2.0

55.7

612

2527

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.9

55.4

832

3821

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

55.4

838

3858

SPAT1139

SPAT

Nutrition survey

2.2

54.9

494

1887

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

250.0

54.8

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

52.9

419

1517

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

52.8

2143

23905

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.3

52.3

420

1529

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

51.3

1228

6430

LAITO, ,

NOMESCO Finland

11.4

51.0

E86

ICD-10 Finland

Volume depletion

2.2

50.5

455

1739

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

20.9

49.9

F0012, G301,

ICD-10 Finland

437.1

49.5

SPAT1301

SPAT

No procedures

1.4

49.3

3751

24667

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

3.2

48.8

207

542

R42

ICD-10 Finland

Dizziness and giddiness

1.4

48.8

3029

19268

SPAT1251

SPAT

Organisation of medication

2.0

48.6

565

2380

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

47.8

1641

9331

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

78.6

47.5

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.2

47.2

198

515

SPAT1172

SPAT

Guidance concerning hydration

2.1

46.7

474

1899

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

46.6

1205

14786

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

13.7

46.1

J01EA01

ATC

trimethoprim; systemic

1.4

45.4

3211

20814

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

44.6

1367

7576

R5110, ,

SPAT

1.7

43.4

878

4392

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

198.4

43.4

AXX01

NOMESCO Finland

Memory assessment

8.7

42.8

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.0

42.4

475

1974

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.9

41.9

568

2521

WZC30

NOMESCO Finland

Teaching

0.6

41.8

634

8889

R1250

NOMESCO Finland

Evaluation of functional capability

2.7

40.9

231

712

WX402

NOMESCO Finland

General anaesthesia

0.6

40.8

696

9461

SPAT1229

SPAT

Assessment of need for aid

1.6

40.6

1173

6407

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

40.6

927

4785

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.0

40.1

478

2030

Z2445

NOMESCO Finland

Psychologist

2.8

39.8

212

633

J01DB01

ATC

cefalexin; oral

1.3

39.7

8270

61904

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

5.8

38.7

109

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.4

37.4

140

339

EB1VA, ,

NOMESCO Finland

0.4

37.2

214

4162

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.8

37.0

559

2567

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

36.4

1671

10020

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.2

36.2

330

1268

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

35.8

4260

29510

F0013, G301,

ICD-10 Finland

+∞

35.7

-2, ,

ICPC

3.6

35.5

124

287

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

34.5

1062

12653

A04AA02

ATC

granisetron; systemic, transdermal

0.3

33.8

126

2974

XX3DW

NOMESCO Finland

Time consuming IT work

0.5

33.0

435

6363

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.5

32.4

1140

6484

AA1AD, ,

SPAT

6.1

32.1

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.1

32.0

310

1220

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

32.0

2043

F22.0

ICD-10 Finland

Delusional disorder

2.8

32.0

173

522

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.7

32.0

579

2806

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.4

31.6

236

834

JN4AD

NOMESCO Finland

Body CT examination

0.6

31.4

474

6681

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

31.2

761

3986

WZC00

NOMESCO Finland

Treatment plan or consultation

0.7

31.1

2031

21315

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.4

30.7

213

727

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.2

30.6

267

1008

G31.0

ICD-10 Finland

Circumscribed brain atrophy

3.9

30.5

199

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

3.7

30.5

103

233

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.0

30.2

336

1393

C10AA01

ATC

simvastatin; oral

1.2

29.6

6049

44340

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

4.0

29.4

186

Z28

ICPC

Limited function/disability (Z)

3.7

29.3

224

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

29.2

769

4101

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

136.3

29.2

F009, F03,

ICD-10 Finland

11.2

29.2

SPAT1050

SPAT

Extensive neurological examination

2.2

29.1

269

1040

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.9

28.9

366

1588

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

28.8

996

5638

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

28.6

135

2857

C10AX09

ATC

ezetimibe; oral

0.6

28.4

745

9200

A10AB05

ATC

insulin aspart; parenteral

1.5

27.9

809

4411

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

6.5

27.5

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

27.4

2018

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

9.3

27.3

F009, G301,

ICD-10 Finland

+∞

27.0

N07AA06, ,

ATC

+∞

27.0

A04AA01

ATC

ondansetron; systemic, rectal

0.5

27.0

248

4065

WX212

NOMESCO Finland

Femoral plexus blockade

2.0

26.9

324

1382

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

26.9

311

1308

U13

ICPC

Bladder symptom/complaint other

1.9

26.7

358

1583

A10BK03

ATC

empagliflozin; oral

0.5

26.4

344

5057

F0024, G301,

ICD-10 Finland

+∞

26.1

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

26.0

462

6249

H02AB06

ATC

prednisolone; systemic

0.8

25.8

3967

37624

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.7

25.0

186

C03DA01

ATC

spironolactone; oral

0.7

24.8

1001

11399

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.7

24.7

702

8537

N28

ICPC

Limited function/disability (N)

2.2

24.6

212

797

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

6.3

24.4

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

24.3

948

10863

F0024, G308,

ICD-10 Finland

+∞

24.1

F0004, G300,

ICD-10 Finland

+∞

24.1

M04AA01

ATC

allopurinol; systemic

0.7

24.1

1210

13284

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

24.0

1485

OAB76

NOMESCO Finland

General guidance on nutrition and food

8.3

23.7

S00.0

ICD-10 Finland

Superficial injury of scalp

2.0

23.7

285

1217

N27

ICPC

Fear of neurological disease other

2.2

23.6

214

822

ZXY02

NOMESCO Finland

Neuropsychologist

5.8

23.5

SPAT1284

SPAT

Extensive health certificate

2.1

23.5

233

927

N02AX02

ATC

tramadol; systemic, rectal

0.8

23.5

3499

33408

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

23.4

1014

5988

KMAK, ,

NOMESCO Finland

1.2

23.3

3639

25697

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

+∞

23.2

R06.0

ICD-10 Finland

Dyspnoea

0.8

22.8

2260

22610

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.2

22.7

202

771

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

22.5

906

10330

C10AA07

ATC

rosuvastatin; oral

0.8

22.3

1951

19833

F05.8

ICD-10 Finland

Other delirium

2.7

22.2

123

377

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

22.2

2025

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

22.1

2069

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.5

22.0

183

E0000UV, ,

ATC

1.2

21.9

3843

27429

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.5

21.7

270

4027

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

21.0

21.5

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

21.4

261

1120

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.4

21.3

149

512

W0A10

NOMESCO Finland

Mapping of psychosocial situation

6.3

21.1

P05

ICPC

Senility, feeling/behaving old

2.8

20.9

110

328

E000001, ,

ATC

1.3

20.7

1773

11631

C04AE01

ATC

ergoloid mesylates; systemic

2.4

20.6

140

475

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

20.6

343

1625

EB4VA, ,

NOMESCO Finland

0.4

20.6

108

2181

G04CB01

ATC

finasteride; oral

1.3

20.5

1863

12317

S18

ICPC

Laceration/cut

0.8

20.5

3655

34410

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.6

20.4

451

5801

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

20.1

722

4113

ICB01, ,

SPAT

4.0

20.1

121

L01BC06

ATC

capecitabine; oral

0.4

19.9

1904

ZXD35

NOMESCO Finland

Usual procedure

1.7

19.7

347

1669

D12

ICPC

Constipation

1.6

19.6

445

2290

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

19.6

1426

14878

P29

ICPC

Psychological sympt/compl other

1.9

19.5

262

1162

L82

ICD-10 Finland

Seborrhoeic keratosis

0.7

19.4

1071

11622

R03AC02

ATC

salbutamol; inhalant

0.8

19.3

3904

36389

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.6

19.3

502

2670

SPAT1058

SPAT

PEF monitoring instruction

0.6

19.2

337

4581

P04

ICPC

Feeling/behaving irritable/angry

4.9

19.1

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

49.5

19.1

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

19.0

2145

21222

L15

ICPC

Knee symptom/complaint

0.8

18.9

1361

14225

SPAT1167

SPAT

Insertion of urinary catheter

1.6

18.9

497

2651

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

18.8

1254

7940

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

2.2

18.8

170

654

W06

ICD-10 Finland

Fall involving bed

2.3

18.7

139

492

WYA30, ,

SPAT

3.3

18.5

180

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.6

18.4

109

347

I67.4

ICD-10 Finland

Hypertensive encephalopathy

6.7

18.4

F0019, G309,

ICD-10 Finland

+∞

18.3

N17

ICPC

Vertigo/dizziness

1.3

18.3

1389

8959

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.3

18.2

Z51.5

ICD-10 Finland

Palliative care

1.4

18.1

1098

6852

L08

ICPC

Shoulder symptom/complaint

0.8

18.0

1188

12579

R33

ICD-10 Finland

Retention of urine

1.3

18.0

1200

7595

Z03

ICPC

Housing/neighbourhood problem

2.9

18.0

244

A27

ICPC

Fear of other disease NOS

1.5

17.9

502

2715

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.0

17.9

194

800

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

17.9

1839

12330

Z60.8

ICD-10 Finland

Other problems related to social environment

3.7

17.7

133

P28

ICPC

Limited function/disability (P)

3.3

17.7

173

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

17.5

839

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

17.5

1566

15935

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.3

17.4

1946

13170

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

17.4

936

F000, G300,

ICD-10 Finland

+∞

17.4

TQW40, ,

SPAT

0.5

17.4

210

3156

A23

ICPC

Risk factor NOS

1.5

17.4

488

2642

SPAT1014

SPAT

Treatment of eyes

1.9

17.3

240

1076

Z51.88

ICD-10 Finland

Other specified medical care

1.9

17.2

219

956

T03

ICPC

Loss of appetite

3.6

17.0

137

HA1RA, ,

SPAT

0.3

16.9

1109

J01MA02

ATC

ciprofloxacin; systemic

1.2

16.8

4386

32269

L75

ICPC

Fracture: femur

1.9

16.8

205

882

F00, F03,

ICD-10 Finland

5.7

16.7

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

16.6

1815

ZXA00

NOMESCO Finland

Right side

1.2

16.5

3069

21896

N03AX14

ATC

levetiracetam; systemic

1.8

16.5

242

1105

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

16.3

543

WW500

NOMESCO Finland

Blood transfusion

0.5

16.2

146

2407

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

6.3

16.2

G04CA02

ATC

tamsulosin; oral

1.2

16.1

3412

24627

WF002

NOMESCO Finland

Radical radiotherapy

0.6

16.1

209

3076

A10BK01

ATC

dapagliflozin; oral

0.6

16.0

253

3531

AA1CG, ,

SPAT

2.8

16.0

233

D07AA02

ATC

hydrocortisone; topical

1.3

15.9

1107

7047

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.4

15.9

924

5728

R11

ICD-10 Finland

Nausea and vomiting

1.4

15.7

864

5309

S01

ICD-10 Finland

Open wound of head

2.2

15.6

137

522

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

15.6

278

1345

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

15.5

1532

10207

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

15.5

1000

I50.1

ICD-10 Finland

Left ventricular failure

0.7

15.5

414

5110

F0022, G308,

ICD-10 Finland

+∞

15.5

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

15.5

F0001, G300,

ICD-10 Finland

+∞

15.5

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

17.2

15.4

F32

ICD-10 Finland

Depressive episode

1.7

15.4

260

1238

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

15.4

512

6059

WX199

NOMESCO Finland

Other local analgesia

0.5

15.4

120

2075

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

15.3

998

6290

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

15.2

457

N02BF01

ATC

gabapentin; oral

0.6

15.2

281

3767

L13

ICPC

Hip symptom/complaint

0.8

15.2

1257

12938

R2110

NOMESCO Finland

Giving the first information

1.5

15.0

466

2578

Z75.0

ICD-10 Finland

Medical services not available in home

3.5

15.0

125

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.7

14.8

273

1333

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

3.5

14.8

122

Y94.1

ICD-10 Finland

Accident in connection with service housing

5.9

14.8

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.4

14.8

657

3897

Y94.0

ICD-10 Finland

Accident at home

1.8

14.7

219

1005

XF606

NOMESCO Finland

Ortostatic test

2.4

14.7

105

366

R54

ICD-10 Finland

Senility

2.3

14.7

109

387

G04BD08

ATC

solifenacin; oral

1.4

14.7

810

4980

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

14.6

948

5974

F0009, G309,

ICD-10 Finland

+∞

14.5

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

14.4

147

2324

ZXA05

NOMESCO Finland

Left side

1.2

14.4

2873

20587

Z2221

NOMESCO Finland

Medical doctor

1.2

14.3

2532

17942

B01AB10

ATC

tinzaparin; parenteral

0.7

14.2

461

5483

R4110, ,

SPAT

0.6

14.2

355

4447

N06AX21

ATC

duloxetine; oral

1.4

14.1

777

4776

G47.3

ICD-10 Finland

Sleep apnoea

0.8

14.1

930

9864

L57.0

ICD-10 Finland

Actinic keratosis

0.8

14.1

1002

10521

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

14.0

1367

N05CD07

ATC

temazepam; oral

1.2

13.9

1678

11430

S82

ICPC

Naevus/mole

0.7

13.9

613

6909

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.6

13.9

193

2786

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

13.9

526

6078

IHZ08, ,

SPAT

4.5

13.8

A10BJ06

ATC

semaglutide; parenteral

0.4

13.8

1226

M01AH05

ATC

etoricoxib; oral

0.9

13.7

3734

34241

GD1AD

NOMESCO Finland

Thorax CT examination

0.6

13.7

235

3210

XF606, ,

SPAT

2.6

13.7

249

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

13.7

148

612

S01.8

ICD-10 Finland

Open wound of other parts of head

2.0

13.6

153

641

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

13.6

214

1000

K86

ICPC

Hypertension uncomplicated

0.8

13.6

945

9953

F0021, G301,

ICD-10 Finland

123.7

13.3

A10AE04

ATC

insulin glargine; parenteral

1.3

13.3

944

6021

R01AD58

ATC

fluticasone, combinations; nasal

0.7

13.2

675

7428

R45.1

ICD-10 Finland

Restlessness and agitation

4.1

13.1

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.4

13.1

526

3063

S09.9

ICD-10 Finland

Unspecified injury of head

1.9

13.0

153

651

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

13.0

3703

27291

R1250, ,

SPAT

1.9

12.9

161

699

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

12.9

1376

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

12.9

301

1564

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.9

12.8

160

695

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

12.7

774

4828

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

12.7

773

8300

K08.3

ICD-10 Finland

Retained dental root

1.4

12.7

657

3998

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

3.7

12.7

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

12.7

1260

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

12.7

214

2931

T05

ICPC

Feeding problem of adult

2.8

12.7

193

N06AX16

ATC

venlafaxine; oral

1.4

12.6

706

4349

TDA90, ,

SPAT

0.6

12.5

217

2955

K59.0

ICD-10 Finland

Constipation

1.4

12.5

681

4176

C09CA06

ATC

candesartan; oral

0.8

12.5

1498

14809

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.7

12.5

322

4004

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

12.4

375

4521

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

12.4

1607

11022

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.7

12.4

219

1058

S28

ICPC

Limited function/disability (S)

2.3

12.4

317

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.6

12.4

233

T08

ICPC

Weight loss

1.9

12.3

162

717

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

12.3

2793

20195

JN4BD

NOMESCO Finland

Extensive body CT

0.7

12.3

682

7418

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.4

12.3

526

3100

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

12.3

173

783

H04AA01

ATC

glucagon; nasal, parenteral

2.4

12.2

309

G03CA04

ATC

estriol; systemic, vaginal

1.3

12.2

1019

6644

U28

ICPC

Limited function/disability (U)

1.9

12.1

144

616

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

12.1

821

8683

WZC30, ,

SPAT

0.6

12.1

181

2555

H02AA02

ATC

fludrocortisone; oral

2.1

12.0

115

455

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.6

12.0

218

TK800

NOMESCO Finland

Hemodialysis

0.3

11.9

933

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

11.9

3053

22284

E66.01

ICD-10 Finland

Obesity due to excess calories

0.5

11.9

132

2030

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

11.8

1623

L03

ICPC

Low back symptom/complaint

0.8

11.8

1604

15668

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

11.8

108

1762

A11CC03

ATC

alfacalcidol; systemic

0.4

11.7

1346

G72.8

ICD-10 Finland

Other specified myopathies

1.7

11.7

194

923

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.7

11.7

N07

ICPC

Convulsion/seizure

4.8

11.6

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

11.6

103

396

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

3.0

11.6

139

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

11.5

322

1746

SPAT1312

SPAT

General health counselling

0.8

11.5

2117

20108

A01

ICPC

Pain general/multiple sites

1.3

11.5

866

5571

SPAT1043

SPAT

Audiometry

0.8

11.5

832

8725

F0023, G308,

ICD-10 Finland

107.2

11.5

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

4.6

11.4

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

4.6

11.4

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.6

11.4

271

1415

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

11.4

496

2932

XCH00

NOMESCO Finland

Eye pressure measurement

0.6

11.4

245

3168

ZXD20

NOMESCO Finland

Day surgery

1.3

11.3

1073

7103

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

2.8

11.3

163

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

11.3

573

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.3

11.3

1220

8202

ZX120

NOMESCO Finland

Intravenous

0.7

11.3

527

5885

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.6

11.3

223

2937

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

20.0

11.2

XA400

NOMESCO Finland

EEG

2.7

11.2

192

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

11.2

318

1730

N05AX12

ATC

aripiprazole; systemic

2.3

11.2

327

SPAT1236

SPAT

Informing family of child’s disability

1.7

11.2

192

922

TPH07

NOMESCO Finland

Cathetrisation of artery

0.8

11.2

753

7974

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

11.1

3032

22220

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.6

11.0

237

1210

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.1

11.0

4688

35471

L03AA13

ATC

pegfilgrastim; parenteral

0.5

11.0

101

1645

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

4.2

10.9

A98

ICPC

Health maint/preventive medicine

1.2

10.9

9007

71232

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

10.9

614

DFF00

NOMESCO Finland

Pure tone audiometry

0.7

10.9

630

6811

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.7

10.9

181

A12AA04

ATC

calcium carbonate; oral

0.3

10.9

838

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

10.8

1606

L90

ICPC

Osteoarthrosis of knee

0.7

10.8

349

4153

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.3

10.8

811

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.7

10.8

452

5138

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

10.8

269

3368

G04BD07

ATC

tolterodine; oral

1.3

10.8

649

4044

Z11

ICPC

Compliance/being ill problem

2.4

10.8

265

F0021, G308,

ICD-10 Finland

+∞

10.6

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

10.6

115

1778

Z08

ICPC

Social welfare problem

2.2

10.5

341

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.3

10.5

273

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

10.5

170

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

10.4

410

2382

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

10.4

969

6402

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

10.4

1214

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.7

10.4

189

923

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

10.4

1473

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

10.4

304

1667

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

10.3

634

R45.5

ICD-10 Finland

Hostility

9.6

10.3

S21

ICPC

Skin texture symptom/complaint

0.8

10.3

886

9101

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.5

10.3

293

1596

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

10.3

738

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

10.3

319

3821

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.4

10.3

471

2812

A04AA55

ATC

palonosetron, combinations; systemic

0.3

10.3

775

R03BA08

ATC

ciclesonide; inhalant

0.7

10.2

300

3634

GD1AA

NOMESCO Finland

Thorax X-ray examination

0.9

10.2

4420

39478

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

10.2

1080

7242

SPAT1285

SPAT

Provision of consultation response

1.4

10.2

483

2900

-, ,

ICD-10 Finland

1.6

10.2

230

1189

N99

ICPC

Neurological disease other

2.0

10.1

108

446

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

10.1

1177

R01AD12

ATC

fluticasone furoate; nasal

0.8

10.1

1137

11331

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

10.1

389

2253

L03AA02

ATC

filgrastim; parenteral

0.5

10.0

1254

R03BB04

ATC

tiotropium bromide; inhalant

0.8

10.0

888

9091

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

10.0

1597

11170

N05AB03

ATC

perphenazine; systemic, rectal

1.6

10.0

223

1148

L01CA04

ATC

vinorelbine; systemic

0.2

10.0

394

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.7

9.9

171

A78

ICPC

Infectious disease other/NOS

2.1

9.9

389

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.0

9.8

117

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.5

9.8

1210

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

9.8

954

SDA03

NOMESCO Finland

Periodontal treatment

0.8

9.8

1815

17265

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.6

9.8

198

2594

Z74.1

ICD-10 Finland

Need for assistance with personal care

8.7

9.8

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.4

9.8

1139

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.5

9.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.2

9.7

1255

8596

N18.8

ICD-10 Finland

Other chronic renal failure

0.6

9.7

135

1940

AA1AA

NOMESCO Finland

Head X-ray examination

2.1

9.7

337

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

11.4

9.7

RD211, ,

NOMESCO Finland

0.6

9.7

136

1949

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.8

9.7

861

8808

F0010, G308,

ICD-10 Finland

+∞

9.7

N29

ICPC

Neurological sympt/complt other

1.7

9.6

176

862

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

9.6

1244

F0001, G301,

ICD-10 Finland

90.7

9.6

62670

ICD-8 Finland

Disorders of menstruation, Postmenopausal bleeding

1.8

9.5

133

602

N43

ICPC

Neurological, Other diagnostic procedure

2.5

9.5

199

A05

ICPC

Feeling ill

1.5

9.5

336

1915

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.7

9.5

175

860

N30

ICD-10 Finland

Cystitis

1.3

9.4

618

3902

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

9.4

1367

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

2.1

9.4

325

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.7

9.4

186

931

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

0.8

9.4

654

6893

S32.5

ICD-10 Finland

Fracture of pubis

1.8

9.4

129

582

S15

ICPC

Foreign body in skin

0.7

9.3

281

3384

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

2.2

9.3

283

R03BB01

ATC

ipratropium bromide; inhalant

0.7

9.3

371

4249

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.2

9.3

375

SPAT1377

SPAT

Polysomnography

0.4

9.2

985

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

9.2

956

9615

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.9

9.2

122

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

9.2

1514

14553

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.2

9.2

1192

8171

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

0.7

9.1

248

3047

250, ,

Kela drug reimbursment

0.3

9.1

715

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

9.9

9.1

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.8

9.1

1488

14309

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

2.1

9.0

314

L89

ICPC

Osteoarthrosis of hip

0.6

9.0

163

2190

M02AA07

ATC

piroxicam; topical

1.1

9.0

3873

29213

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.3

9.0

230

SPAT1244

SPAT

Occupational therapy

1.9

9.0

105

449

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

8.9

190

2458

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

1.8

8.9

123

555

A10AE05

ATC

insulin detemir; parenteral

1.4

8.9

455

2766

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.4

8.9

769

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.7

8.9

152

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

0.9

8.9

2350

21756

R4135

NOMESCO Finland

Rehabilitation for hearing problems

0.5

8.9

101

1536

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.8

586

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

8.8

477

T93

ICPC

Lipid disorder

0.7

8.8

293

3460

F01.9

ICD-10 Finland

Vascular dementia, unspecified

1.5

8.8

284

1592

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.7

8.7

154

748

D82

ICPC

Teeth/gum disease

0.8

8.7

1611

15339

F0014, G309,

ICD-10 Finland

82.4

8.7

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

0.6

8.7

148

2014

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

8.7

420

4659

F002, G308,

ICD-10 Finland

10.0

8.6

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

0.5

8.6

100

1509

S22.3

ICD-10 Finland

Fracture of rib

1.3

8.6

628

4028

HMAK, ,

NOMESCO Finland

0.7

8.5

410

4555

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.0

8.5

105

PD5AD

NOMESCO Finland

CT of aorta

0.5

8.5

1210

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

8.5

904

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

4.2

8.5

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.5

8.5

268

1496

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.5

8.4

1118

TNC33

NOMESCO Finland

Custom moulded brace, elbow or forearm

3.5

8.4

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

8.4

1409

9897

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.7

8.4

231

2828

N05CF01

ATC

zopiclone; oral

1.1

8.4

3764

28438

R02

ICPC

Shortness of breath/dyspnoea

0.8

8.4

941

9387

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

1.8

8.3

130

610

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.1

8.3

263

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

8.3

228

2793

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.3

8.3

668

WW200, ,

SPAT

0.8

8.3

1220

11854

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

0.7

8.3

427

4693

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

8.3

1496

10578

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

8.3

484

R96

ICPC

Asthma

0.8

8.3

473

5120

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

8.2

378

4229

V613A

ICD-9 Finland

Other family circumstances, Problems with aged parents or in-laws

10.1

8.2

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.4

8.2

810

HA1AA

NOMESCO Finland

X-ray mammography

0.7

8.2

313

3608

SPAT1111

SPAT

Planning of analgesia

1.8

8.2

114

517

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

8.2

1132

11064

SPAT1125

SPAT

Stoma care and guidance

1.5

8.2

224

1213

C08CA13

ATC

lercanidipine; oral

0.8

8.2

1213

11778

Z3226

NOMESCO Finland

Physiotherapist

1.2

8.2

1697

12139

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.4

8.2

194

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.6

8.2

107

1559

115

Kela drug reimbursment

Breast cancer

0.7

8.1

393

4361

WYA20, ,

SPAT

2.4

8.1

200

UDC00

NOMESCO Finland

Ear microscopy

0.7

8.1

376

4195

D10

ICPC

Vomiting

1.6

8.0

201

1067

R03AK08

ATC

formoterol and beclometasone; inhalant

0.6

8.0

122

1709

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

8.0

884

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.2

8.0

248

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.7

8.0

137

661

R40.2

ICD-10 Finland

Coma, unspecified

1.9

8.0

433

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

8.0

1110

7662

HA1AA, ,

SPAT

0.3

8.0

565

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

7.9

1281

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.0

7.9

359

SPAT1059

SPAT

Spirometry at the office

0.7

7.9

226

2745

A01AB09

ATC

miconazole; local oral

1.2

7.9

880

5936

F10.73

ICD-10 Finland

Residual or late-onset psychosis caused by alcohol dementia

3.5

7.9

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.7

7.9

324

3687

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.7

7.8

222

2699

GD1AA, ,

SPAT

0.6

7.8

179

2274

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

7.8

222

2698

S01EX03, ,

ATC

1.4

7.8

339

2010

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.6

7.8

182

952

N18.0

ICD-10 Finland

End-stage renal disease

0.4

7.8

670

W18

ICD-10 Finland

Other fall on same level

2.0

7.8

328

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.3

7.8

531

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

7.8

871

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

7.8

894

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

7.7

303

1763

F009, G308,

ICD-10 Finland

74.2

7.7

N05AL01

ATC

sulpiride; systemic

1.8

7.7

118

551

XQ848

NOMESCO Finland

Dermatological photography

0.6

7.7

113

1597

L03AA14

ATC

lipegfilgrastim; parenteral

0.3

7.7

542

H13

ICPC

Plugged feeling ear

0.9

7.7

1649

15530

TFP20

NOMESCO Finland

Cardiodefibrillation

0.8

7.7

541

5695

WX722

NOMESCO Finland

PEEP

0.7

7.7

196

2434

S72.2

ICD-10 Finland

Subtrochanteric fracture

1.8

7.7

116

540

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

4.0

7.7

C10AA02

ATC

lovastatin; oral

1.3

7.7

586

3781

T82

ICPC

Obesity

0.4

7.6

689

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

0.5

7.6

1286

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

7.6

1221

I95.9

ICD-10 Finland

Hypotension, unspecified

1.6

7.6

174

905

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

2.5

7.6

165

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

0.6

7.6

102

1476

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

7.6

257

3024

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

1.8

7.6

119

561

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

7.5

850

T11

ICPC

Dehydration

3.5

7.5

S06.3

ICD-10 Finland

Focal brain injury

1.7

7.5

124

592

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

7.5

149

1955

207

Kela drug reimbursment

Chronic arrhythmias

0.9

7.5

1853

17270

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.1

7.5

282

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.0

7.5

181

SGA01

NOMESCO Finland

Emergency treatment

0.7

7.5

382

4203

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

7.5

255

1446

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

7.5

728

4838

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

7.5

800

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.2

7.4

465

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.5

7.4

225

1249

F32.0

ICD-10 Finland

Mild depressive episode

1.7

7.3

123

591

H02BX01

ATC

methylprednisolone, combinations; systemic

1.3

7.3

602

3921

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

7.3

746

L17

ICPC

Foot/toe symptom/complaint

0.9

7.3

2078

19171

D19

ICPC

Teeth/gum symptom/complaint

0.8

7.3

1194

11494

XQ855, ,

SPAT

2.0

7.3

297

D06BB10

ATC

imiquimod; topical

0.7

7.3

272

3142

Z01.2

ICD-10 Finland

Dental examination

0.9

7.3

2371

21674

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.7

7.3

321

3608

R01AD59

ATC

mometasone, combinations; nasal

0.3

7.2

598

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.6

7.2

148

750

L86

ICPC

Back syndrome with radiating pain

0.7

7.2

254

2966

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

0.7

7.2

289

3301

M05BA07

ATC

risedronic acid; oral

1.3

7.2

396

2440

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.0

7.2

298

C02AC05

ATC

moxonidine; oral

0.7

7.2

277

3184

N05AH02

ATC

clozapine; systemic

2.5

7.2

150

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

7.2

4568

35138

L02BG06

ATC

exemestane; oral

0.4

7.1

643

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

7.1

488

3103

WVA30, ,

SPAT

0.7

7.1

200

2436

R74

ICPC

Upper respiratory infection acute

0.8

7.1

1025

9986

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

7.1

321

1916

B01AF01

ATC

rivaroxaban; oral

0.8

7.1

1006

9811

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.5

7.1

146

Z51.0

ICD-10 Finland

Radiotherapy session

0.4

7.1

651

S29

ICPC

Skin symptom/complaint other

0.8

7.0

1312

12498

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

7.0

234

F0022, G301,

ICD-10 Finland

37.1

7.0

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.7

7.0

241

2824

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.3

7.0

575

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

0.8

7.0

883

8706

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

7.0

179

2218

R18

ICD-10 Finland

Ascites

0.5

7.0

1024

EP1AE

NOMESCO Finland

Neck ultrasound examination

0.7

7.0

236

2773

L01AX03

ATC

temozolomide; systemic

0.0

6.9

145

SPAT1042

SPAT

Guidance concerning balance maintenance

2.1

6.9

269

R03DA04

ATC

theophylline; systemic, rectal

0.8

6.9

530

5519

K05.30

ICD-10 Finland

Periodontitis complex

0.8

6.9

695

7016

A69.2

ICD-10 Finland

Lyme disease

0.7

6.9

202

2438

NG1AA, ,

SPAT

0.5

6.9

987

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.1

6.9

2194

16185

WX111

NOMESCO Finland

Local infiltration anesthesia

0.6

6.9

141

1833

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

6.9

233

2738

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

6.9

1382

TFP34

NOMESCO Finland

Electrophysiological investigation

0.5

6.9

953

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.8

6.9

435

4640

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

6.9

1191

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.4

6.9

594

JN3AD

NOMESCO Finland

Abdominal CT examination

0.8

6.8

668

6764

UDQ12

NOMESCO Finland

Flexible laryngoscopy

0.7

6.8

211

2522

P15

ICPC

Chronic alcohol abuse

1.8

6.8

438

I64

ICD-10 Finland

Stroke, not specified as haemorrhage or infarction

1.8

6.8

444

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

6.8

859

5870

S01BC05

ATC

ketorolac; ophthalmic

1.3

6.8

551

3582

F0002, G300,

ICD-10 Finland

66.0

6.8

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

0.4

6.8

603

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

6.8

328

F01.24

ICD-10 Finland

Subcortical vascular dementia other additional symptoms of mixed type

3.2

6.8

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

6.8

527

3411

S16

ICPC

Bruise/contusion

1.4

6.8

313

1878

F0003, G300,

ICD-10 Finland

+∞

6.8

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.3

6.8

438

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

6.8

1578

11386

A02

ICPC

Chills

2.1

6.7

250

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

0.6

6.7

149

1903

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.3

6.7

584

3831

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

6.7

642

4259

137

Kela drug reimbursment

Uraemia requiring dialysis

0.2

6.7

291

EBA00

NOMESCO Finland

Extraction of tooth

1.1

6.7

2570

19183

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

0.3

6.7

462

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.6

6.7

138

702

A10BB12

ATC

glimepiride; oral

1.2

6.7

977

6777

D07CC01

ATC

betamethasone and antibiotics; topical

1.2

6.7

946

6543

G04BD10

ATC

darifenacin; oral

1.9

6.7

365

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.4

6.6

645

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.3

6.6

166

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

4.0

6.6

OAB43, ,

SPAT

0.5

6.6

1005

T68

ICD-10 Finland

Hypothermia

2.3

6.6

182

X31

ICD-10 Finland

Exposure to excessive natural cold

2.8

6.6

S42.0

ICD-10 Finland

Fracture of clavicle

1.5

6.6

195

1077

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

0.5

6.6

1015

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

0.2

6.6

259

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.2

6.6

240

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

0.7

6.6

257

2943

P18

ICPC

Medication abuse

2.7

6.6

103

M02AA15

ATC

diclofenac; topical

1.3

6.5

618

4095

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.3

6.5

628

4170

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

6.5

543

R05FB02

ATC

cough suppressants and expectorants; systemic

1.1

6.5

3881

29703

R05

ICPC

Cough

0.9

6.5

1446

13589

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.3

6.5

451

2876

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.2

6.5

401

K85

ICPC

Elevated blood pressure

0.9

6.5

1361

12847

N02BF02

ATC

pregabalin; oral

0.7

6.5

196

2350

C34.2

ICD-10 Finland

Malignant neoplasm: Middle lobe, bronchus or lung

0.1

6.5

184

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.8

6.5

408

4352

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

6.5

1207

8556

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

1.8

6.4

381

G40

ICD-10 Finland

Epilepsy

2.2

6.4

200

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

0.6

6.4

116

1550

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.6

6.4

117

1560

L01CB01

ATC

etoposide; systemic

0.2

6.4

219

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

0.8

6.4

394

4217

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

0.6

6.4

125

1640

P71

ICPC

Organic psychosis other

8.9

6.4

L02BG04

ATC

letrozole; oral

0.7

6.4

269

3044

CS494

NOMESCO Finland

Other visual field testing

0.6

6.4

1322

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.6

6.4

116

1548

N05AN01

ATC

lithium; oral

1.8

6.4

412

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.3

6.4

411

2595

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

0.7

6.4

335

3665

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

6.4

318

128

Kela drug reimbursment

Cancers of female genital organs

0.5

6.4

760

SPAT1016

SPAT

Examination of vision

0.7

6.4

216

2535

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.7

6.4

231

2679

F30.1

ICD-10 Finland

Mania without psychotic symptoms

5.8

6.4

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

5.8

6.4

ACC51

NOMESCO Finland

Release of median nerve

0.7

6.4

287

3212

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

0.7

6.3

223

2601

R44.1

ICD-10 Finland

Visual hallucinations

2.0

6.3

273

K02.0

ICD-10 Finland

Caries limited to enamel

0.8

6.3

450

4726

-44

ICPC

Preventive immunization/medic

0.8

6.3

632

6381

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

6.3

497

5156

IHA10, ,

SPAT

2.1

6.3

240

P19

ICPC

Drug abuse

3.1

6.3

M54.4

ICD-10 Finland

Lumbago with sciatica

0.8

6.3

839

8231

WX290

NOMESCO Finland

Other blockage of nerve

0.9

6.3

1867

17193

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.7

6.3

323

3544

HA1AE, ,

SPAT

0.2

6.3

281

SPAT1263

SPAT

Sampling

1.1

6.3

3947

30286

N81.6

ICD-10 Finland

Rectocele

0.7

6.2

304

3362

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.4

6.2

331

2033

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.6

6.2

104

1415

K80

ICPC

Cardiac arrhythmia NOS

0.8

6.2

474

4933

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.9

6.2

3503

31058

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

2.3

6.2

172

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.5

6.1

816

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

8.2

6.1

R26

ICD-10 Finland

Abnormalities of gait and mobility

2.6

6.1

107

ZXE10

NOMESCO Finland

More than one and less than three hours

1.1

6.1

3510

26792

S20.2

ICD-10 Finland

Contusion of thorax

1.3

6.1

395

2496

180

Kela drug reimbursment

Interferon alfa

0.1

6.1

194

R06AE07

ATC

cetirizine; oral

1.1

6.1

3269

24862

Z49.2

ICD-10 Finland

Other dialysis

0.2

6.1

212

N03AX12

ATC

[U] gabapentin; oral

0.8

6.1

1024

9839

R44.0

ICD-10 Finland

Auditory hallucinations

2.4

6.1

147

Y94.8

ICD-10 Finland

Other leisure activity accident

1.5

6.1

188

1049

N05AC01

ATC

periciazine; systemic

2.4

6.1

142

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

3.9

6.1

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.4

6.1

665

OAB48, ,

SPAT

0.5

6.0

789

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

1.5

6.0

156

838

C09DA03

ATC

valsartan and diuretics; oral

0.7

6.0

257

2901

F0020, G301,

ICD-10 Finland

18.5

6.0

N02AJ13

ATC

tramadol and paracetamol; systemic

0.5

6.0

876

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019309) Folate [Moles/volume] in Red Blood Cells

4524

20550

2.29

307.65

1.9

1.8

1190.85

1157.66

nmol/l

1.43

3227

15098

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

696

313

19.36

307.65

1.0

57.01

36.23

ng/l

15.01

521

175

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

687

313

19.10

307.65

1.0

418.51

271.73

ng/l

17.02

521

177

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

696

314

19.30

307.65

1.0

556.79

740.28

ng/l

9.42

520

170

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

670

1220

4.73

263.18

1.2

1.3

464.21

602.77

mg/l

4.79

602

1157

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

605

1018

5.10

260.12

1.2

1.4

284.53

1312.06

e6/l

3.66

465

850

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

604

1018

5.09

259.21

1.2

1.3

5.10

24.77

e6/l

2.42

451

804

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

610

1056

4.96

253.95

1.1

1.2

3.79

3.91

mmol/l

1.57

567

976

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3545

17207

1.98

225.43

3.0

2.46

2.47

mmol/l

11.20

3091

14642

(3044290) Cell count panel - Cerebral spinal fluid

532

958

4.74

211.20

1.1

1.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6136

37089

1.73

180.69

2.5

2.2

91.39

92.72

pmol/l

1.31

3156

18945

(3021960) Folate [Moles/volume] in Serum or Plasma

4145

22455

1.79

178.66

1.7

1.6

20.60

20.21

nmol/l

0.68

3682

18741

(3015377) Calcium [Moles/volume] in Serum or Plasma

4952

28465

1.73

171.85

2.6

3.2

2.35

mmol/l

0.81

4220

23925

(3023410) Appearance of Cerebral spinal fluid

302

412

6.17

160.86

1.3

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

347

707

4.13

117.78

3.1

3.7

311.69

327.69

umol/l

1.06

278

570

(3031040) Bacteria [#/volume] in Urine by Automated count

7638

52745

1.52

98.80

6.1

5.6

3093.15

1556.36

e6/l

1.28

214

891

(3024561) Albumin [Mass/volume] in Serum or Plasma

5682

37095

1.49

95.00

3.6

4.4

34.50

33.96

g/l

10.28

5087

33778

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2045

10930

1.65

81.56

1.9

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2045

10990

1.64

79.62

1.9

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

237

498

3.98

77.21

1.2

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2313

26937

0.64

77.12

3.2

3.7

10.07

10.22

mg/mmol

0.04

1412

16841

(3012516) Albumin [Mass/volume] in Urine

2190

25291

0.65

68.12

2.7

3.2

453.80

378.50

mg/l

0.31

1362

16148

(3009508) Creatinine [Moles/volume] in Urine

2199

25367

0.65

68.01

2.6

3.1

6.94

6.64

mmol/l

2.69

1729

20470

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4654

30561

1.41

67.07

2.1

2.2

78.04

81.00

nmol/l

8.62

3971

26018

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2698

16006

1.50

66.55

1.9

—

(3026008) Bacteria identified in Urine by Culture

4634

30492

1.41

65.55

3.8

3.7

—

(3003338) MCHC [Mass/volume]

7245

51591

1.39

62.65

26.2

26.3

329.64

330.07

g/l

3.62

7046

50875

(40768804) Tissue Pathology biopsy report

2662

29040

0.69

59.93

2.2

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5722

39492

1.37

58.10

4.4

5.8

1.22

1.21

mmol/l

10.25

5065

35280

(3023368) Bacteria identified in Blood by Culture

4074

26666

1.39

57.23

3.9

4.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4311

28526

1.38

56.48

2.5

2.1

—

(3018418) pH of Serum or Plasma

3965

25900

1.39

56.09

2.9

4.0

7.40

0.93

520

5018

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3060

19416

1.40

50.28

1.8

439.88

20719141.87

pmol/l

8.74

2442

15194

(1761868) Lipid panel - Serum or Plasma

1339

16129

0.64

47.70

3.0

3.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1155

6203

1.59

43.12

1.8

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

670

9316

0.57

42.95

1.2

16.39

16.35

u/ml

0.00

162

3036

(3019150) Specific gravity of Urine by Refractometry

2598

16438

1.38

42.16

5.3

5.0

1.02

kg/l

0.60

399

2778

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6105

43786

1.30

41.26

4.9

6.5

1.22

1.21

mmol/l

24.66

5149

36442

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6668

61258

0.77

40.68

3.5

4.3

1.19

1.24

mmol/l

8.52

5606

53135

(3011397) Hemoglobin [Presence] in Urine by Test strip

2786

17937

1.36

40.28

4.4

4.3

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6937

63281

0.77

39.06

3.9

4.8

1.47

1.45

mmol/l

3.92

5959

55564

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1517

17085

0.69

36.95

1.5

1.6

1.19

1.27

mmol/l

5.41

1347

13841

(3017181) Myelocytes/100 leukocytes in Blood

453

6748

0.54

36.72

2.9

3.7

1.13

0.92

0.42

159

2535

(3002179) Metamyelocytes/100 leukocytes in Blood

389

6069

0.51

36.66

2.8

3.6

0.66

0.68

0.04

121

2149

(3021440) Promyelocytes/100 leukocytes in Blood

424

6415

0.53

36.17

3.0

3.7

0.14

0.10

0.48

133

2217

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9004

68539

1.32

35.77

19.5

19.4

32.31

28.14

mg/l

19.84

7687

57481

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7078

64049

0.78

34.64

3.9

4.8

4.36

4.33

mmol/l

0.84

6107

56777

(4035726) Immunohistochemistry procedure

492

6986

0.56

33.60

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1026

5675

1.53

33.30

1.5

—

(3025159) Blasts/100 leukocytes in Blood

400

5955

0.54

32.20

3.0

3.7

0.13

0.42

1.51

110

1803

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

799

9934

0.64

31.64

1.2

1.3

39.64

42.92

iu/ml

0.22

233

3084

(3013512) EKG study

2560

25857

0.77

29.41

4.3

4.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1967

20587

0.75

29.26

2.3

2.9

7394.68

7169.42

umol/l

0.06

1552

17137

(3037522) Nuclear Ab [Titer] in Serum

593

7727

0.61

28.73

1.2

1.3

427.56

522.80

titre

1.02

119

1819

(3037467) Urinalysis macro (dipstick) panel - Urine

7042

52710

1.24

27.44

5.1

—

(3015736) pH of Urine

4179

29568

1.25

27.35

4.2

6.03

5.86

1.08

771

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

418

5752

0.58

25.15

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

467

2292

1.71

24.64

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

281

1178

1.99

24.56

1.1

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

593

3101

1.60

24.45

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

466

2292

1.70

24.40

1.4

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3714

26216

1.24

24.01

2.2

2.1

260.93

220.12

u/l

1.75

3421

24263

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8153

62398

1.23

23.72

4.9

5.0

2.02

2.13

mu/l

3.40

7227

54905

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3467

24339

1.24

23.44

2.3

2.4

2.97

3.21

mg/l

6.93

2815

20432

(3019550) Sodium [Moles/volume] in Serum or Plasma

9258

72064

1.24

21.59

23.4

23.6

139.70

139.42

mmol/l

14.95

8889

69957

(40761511) CBC panel - Blood by Automated count

8842

68509

1.23

21.39

18.1

19.0

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

9263

72131

1.24

21.37

23.5

23.8

4.00

4.01

mmol/l

6.23

8877

69915

(3028026) IgM [Mass/volume] in Serum or Plasma

257

3858

0.54

21.15

1.9

1.8

2.12

1.45

g/l

1.05

205

3402

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3743

35136

0.82

20.30

2.4

2.8

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6739

51016

1.20

19.93

3.7

4.0

15.19

15.27

pmol/l

1.41

5852

44540

(3010813) Leukocytes [#/volume] in Blood

9306

72712

1.23

19.42

27.4

28.6

7.19

7.07

e9/l

2.28

8820

69798

(3009542) Hematocrit [Volume Fraction] of Blood

9302

72684

1.23

19.36

27.4

28.6

37.96

38.47

9.54

8165

66241

(3035350) Ketones [Presence] in Urine by Test strip

4976

36734

1.20

19.16

4.5

0.00

estimate

0.28

738

7701

(3035941) MCH [Entitic mass]

9301

72702

1.23

19.12

27.3

28.5

30.39

30.41

0.55

8953

71000

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4712

34618

1.20

19.12

4.5

4.6

55.80

93.65

ng/l

1.74

3669

27968

(3026361) Erythrocytes [#/volume] in Blood

9301

72706

1.23

19.09

27.4

28.6

4.24

4.30

e12/l

28.50

8801

69768

(3024731) MCV [Entitic volume]

9301

72706

1.23

19.09

27.3

28.5

91.97

92.00

0.19

8955

71007

(3007461) Platelets [#/volume] in Blood

9300

72698

1.23

19.08

27.4

28.6

235.77

237.01

e9/l

0.98

8847

70122

(3000963) Hemoglobin [Mass/volume] in Blood

9301

72716

1.23

19.00

27.6

28.8

127.63

129.81

g/l

37.28

8940

71035

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7545

66266

0.84

18.77

4.6

5.5

2.47

2.46

mmol/l

0.23

6581

58500

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

111

357

2.58

18.33

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

1578

16124

0.78

18.30

1.2

1.3

—

(3002256) Pathology report gross observation

920

10130

0.73

18.24

1.4

—

(40761535) Cells panel - Urine sediment

1174

7397

1.34

18.17

3.8

3.7

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2072

14070

1.26

18.10

3.1

3.2

2.73

2.79

e6/l

0.09

1118

8051

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4254

31099

1.19

17.87

3.5

3.6

—

0.61

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

133

472

2.34

17.82

1.1

—

3.34

—

(3022145) Colonoscopy Study observation

671

7690

0.70

16.92

1.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6268

47530

1.18

16.74

4.4

4.7

7.02

6.93

mmol/l

2.28

5872

44719

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

902

9836

0.74

16.71

4.2

4.9

34.78

34.32

0.53

517

6260

(3021601) Nitrite [Presence] in Urine by Test strip

4920

36588

1.18

16.57

5.9

6.0

0.00

estimate

0.50

628

6955

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

649

3765

1.44

16.46

1.4

1.5

1.64

1.63

0.12

532

2986

(4200892) Spirometry reversibility

423

5238

0.65

16.04

1.4

—

(3018095) Leukocytes [#/volume] in Urine

4060

29764

1.19

16.03

4.1

183.15

141.36

e6/l

0.89

2841

22050

(3005719) IgG [Mass/volume] in Serum or Plasma

376

4770

0.64

15.98

2.6

10.69

10.78

g/l

0.11

318

4297

(3021589) Normoblasts [#/volume] in Blood

3333

31128

0.84

15.92

8.6

10.9

0.00

e9/l

1.50

2578

25219

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

512

6090

0.68

15.84

2.7

2.9

55.09

55.52

ml/min/173m2

0.13

206

2879

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2537

17849

1.22

15.62

4.2

4.4

226.32

427.82

ng/l

2.67

2294

15927

(3009261) Glucose [Presence] in Urine by Test strip

4967

37089

1.17

15.59

4.5

0.00

estimate

1.08

633

6895

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

217

3116

0.57

15.31

2.7

4.0

230.45

87.39

u/ml

1.12

203

2971

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

137

526

2.16

15.30

2.4

2.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

449

5433

0.67

15.18

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

3658

33770

0.85

15.00

4.5

5.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2152

14977

1.22

14.66

2.9

3.0

1.60

1.47

e6/l

0.25

1187

8888

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

958

10152

0.76

14.42

2.7

3.7

20.54

22.90

ug/l

0.11

766

8505

(3024891) Influenza virus A+B Ag [Presence] in Specimen

328

1715

1.59

13.66

1.2

—

(36304419) Bacteria [Presence] in Urine

3171

23048

1.18

13.29

3.4

3.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

810

8667

0.75

13.03

3.8

5.8

11.57

12.27

mmol/l

1.75

734

8055

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7258

63239

0.86

13.00

19.0

18.9

67.65

67.16

ml/min/173m2

1.25

5734

52817

(40768797) Stomach Pathology biopsy report

979

10192

0.77

12.81

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1116

11373

0.79

12.22

2.7

3.6

245.72

252.49

u/l

0.82

982

10580

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1199

12064

0.80

11.71

3.4

4.9

1.02

1.05

mmol/l

2.63

1031

10903

(3029937) Albumin [Presence] in Urine by Test strip

2803

20363

1.17

11.54

5.1

4.8

0.00

estimate

1.34

584

6566

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

123

1907

0.53

11.41

1.7

2.7

91.77

807.56

u/ml

3.67

102

1733

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

201

2723

0.60

11.41

1.5

1.6

84.44

237.09

titre

—

141

(3013139) Helicobacter pylori Ag [Presence] in Stool

373

4414

0.69

11.24

1.3

1.2

—

(3000492) Spirometry study

433

4969

0.71

10.97

1.5

1.6

—

(3002582) Erythrocytes [#/volume] in Urine

3578

26576

1.15

10.90

3.6

99.83

118.14

e6/l

0.40

2708

20826

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1057

7071

1.25

10.21

1.5

1.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

160

2.74

10.09

1.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

158

2180

0.59

9.71

1.2

0.51

0.97

u/ml

0.67

213

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1340

9254

1.22

9.59

2.5

5.58

6.06

ug/l

0.52

971

7684

(3006270) Folate [Moles/volume] in Blood

177

872

1.68

9.47

1.3

1.2

324.87

309.26

nmol/l

0.44

145

636

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

122

1789

0.56

9.44

1.4

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

345

1979

1.45

9.43

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

289

3467

0.68

9.41

2.6

2.7

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

231

2.36

9.34

3.2

2.8

27.14

29.50

umol/l

1.11

167

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

209

2672

0.64

9.31

1.5

1.6

38.24

u/l

0.00

159

2211

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1020

6871

1.24

9.26

2.2

2.3

37.46

38.24

u/l

0.05

834

5793

(40768793) Breast Pathology biopsy report

1522

0.53

9.23

1.2

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1072

10653

0.81

9.21

1.4

1.5

2.73

2.77

g/l

0.15

456

5735

(3013115) Eosinophils [#/volume] in Blood

4173

37231

0.88

9.14

4.6

5.4

0.20

e9/l

0.19

3385

31707

(3022096) Basophils/100 leukocytes in Blood

3694

33210

0.88

9.14

4.6

5.6

0.61

0.62

0.26

3309

30386

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

495

5401

0.74

9.12

1.3

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

347

2006

1.44

9.11

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

115

1696

0.55

9.09

1.5

1.7

13.57

12.58

mg/l

0.55

1523

(42529406) Shigella sp [Presence] in Stool by Culture

347

2008

1.44

9.07

1.2

—

(3014271) Vancomycin [Susceptibility]

162

790

1.70

9.03

3.4

3.1

—

(3019069) Monocytes/100 leukocytes in Blood

3828

34317

0.88

9.02

4.9

5.9

8.86

8.98

1.27

3441

31422

(3006504) Eosinophils/100 leukocytes in Blood

3808

34144

0.88

8.99

4.6

5.6

2.83

2.79

0.46

3422

31234

(3005322) IgE [Units/volume] in Serum or Plasma

224

2800

0.65

8.99

1.2

1.3

254.98

236.95

u/ml

0.15

199

2527

(3001604) Monocytes [#/volume] in Blood

4029

35998

0.88

8.99

4.5

5.2

0.63

0.64

e9/l

0.69

3282

30268

(3042631) Mycobacterium sp identified in Specimen

1497

0.53

8.96

2.2

2.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8934

70917

1.14

8.95

21.8

23.2

85.18

87.39

umol/l

7.38

8927

70870

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

591

0.26

8.93

1.2

1.4

—

(3006315) Basophils [#/volume] in Blood

4051

36166

0.88

8.89

4.5

5.2

0.04

e9/l

0.90

3298

30435

(4094501) Cardiovascular stress test using bicycle ergometer

114

1663

0.56

8.69

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

169

2227

0.62

8.64

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

112

1630

0.56

8.48

3.6

3.4

2.20

1.54

0.65

1385

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1492

0.54

8.47

1.2

3.98

5.00

u/ml

0.35

257

(3002030) Lymphocytes/100 leukocytes in Blood

3900

34826

0.89

8.47

4.9

5.8

24.02

24.84

4.36

3513

31948

(3018010) Neutrophils/100 leukocytes in Blood

3821

34162

0.89

8.46

4.7

5.5

60.51

59.70

3.62

3452

31330

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1475

0.54

8.36

1.2

4.32

6.07

u/ml

—

160

(3019198) Lymphocytes [#/volume] in Blood

4142

36805

0.89

8.20

4.6

5.4

1.74

1.86

e9/l

2.05

3399

31648

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

510

3209

1.32

8.01

1.8

2.2

1166.15

548.97

ug/l

0.82

473

3029

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

129

1777

0.59

7.96

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1149

0.50

7.92

2.7

3.6

172.38

2860.72

iu/ml

—

162

(3013650) Neutrophils [#/volume] in Blood by Automated count

4782

42078

0.89

7.85

6.0

8.1

4.67

4.47

e9/l

5.01

3971

36040

(3006653) Thiamine [Moles/volume] in Blood

280

2.09

7.65

1.1

132.70

134.32

nmol/l

0.10

280

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

138

1850

0.61

7.64

2.1

2.5

1.67

1.90

mg/l

2.40

111

1608

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1211

0.52

7.64

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

253

2.15

7.64

1.1

41.79

45.75

mg/l

0.34

215

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

135

1798

0.61

7.30

1.2

1.4

1.13

1.15

g/l

0.30

118

1678

(40761536) Microorganisms panel - Urine sediment

648

6631

0.79

7.29

4.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3665

27838

1.12

7.22

5.1

4.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

120

1636

0.60

7.15

1.3

1.4

—

(3030467) Casts [#/volume] in Urine by Automated count

3230

24367

1.12

7.14

3.4

3.5

0.64

0.52

e6/l

1.51

2449

19114

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1270

0.55

7.14

1.2

2.58

6.25

u/ml

—

102

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

132

1752

0.62

7.05

1.2

1.4

0.24

0.23

g/l

0.08

115

1633

(3000012) Reticulocyte production index

129

1720

0.61

7.02

2.0

2.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

116

1574

0.60

6.80

1.2

41.38

44.44

u/ml

—

(3007566) Smooth muscle Ab [Titer] in Serum

108

1491

0.59

6.79

1.1

82.00

131.72

titre

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

123

606

1.68

6.72

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.02

6.62

1.1

1.2

50.10

47.50

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

368

2275

1.34

6.59

1.2

—

(40768795) Lymph node Pathology biopsy report

723

0.43

6.56

1.1

1.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3640

32280

0.90

6.52

2.9

3.4

2319.76

2152.54

ng/l

0.96

3051

28214

(3023419) Bacteria identified in Sputum by Culture

102

1409

0.59

6.45

1.9

2.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

992

0.52

6.36

3.3

57.02

58.14

0.12

794

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.81

6.33

1.1

1.2

20.80

47.85

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

450

4727

0.78

6.33

1.3

1.4

—

(40768443) Skin Pathology biopsy report

338

3686

0.75

6.29

1.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

112

1500

0.61

6.26

2.8

3.4

60.44

59.56

0.31

112

1500

(3008037) Lactate [Moles/volume] in Venous blood

236

2718

0.71

6.24

3.2

3.7

1.77

1.64

mmol/l

1.13

231

2667

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

108

1457

0.61

6.23

2.4

3.1

—

(3000494) Fungus identified in Specimen by Culture

806

7926

0.83

6.20

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

2579

19349

1.12

6.12

3.4

4.0

80.51

81.26

0.74

2499

18876

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

596

0.40

6.08

2.7

3.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

239

2.04

6.01

1.0

1.1

285.56

317.56

mg/l

0.55

208

(4034850) Laboratory test

371

2330

1.32

6.00

11.8

13.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1206

0.58

6.00

1.2

1.3

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

4.25

5.99

1.1

1.3

15.56

15.76

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1459

10562

1.16

5.96

9.7

9.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

129

2.43

5.89

3.6

3.1

0.39

0.46

u/field

0.21

129

(3034860) Kappa light chains.free [Mass/volume] in Serum

337

3639

0.76

5.87

2.7

2.9

53.46

89.69

mg/l

1.29

282

2948

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1166

0.58

5.85

1.2

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

226

2584

0.72

5.76

1.6

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

438

1.74

5.76

1.1

1.2

2.00

2.21

mmol/l

1.62

395

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

927

0.53

5.74

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

927

0.53

5.74

1.5

1.3

0.12

0.29

nmol/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

869

0.52

5.66

1.4

1.5

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

338

3629

0.76

5.66

2.6

2.9

47.90

54.81

mg/l

0.33

286

2936

(3000330) Specific gravity of Urine by Test strip

502

5132

0.80

5.65

3.9

4.3

—

(4281824) Cell count and differential, peritoneal fluid

777

0.50

5.57

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

441

4566

0.79

5.55

1.3

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

2881

25681

0.90

5.49

2.3

2.6

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

922

0.54

5.44

1.4

1.3

0.69

0.72

nmol/l

0.18

876

(40760888) Immunoglobulin light chains.free panel - Serum

244

2726

0.73

5.40

2.8

3.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

228

0.22

5.39

1.0

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7317

58074

1.09

5.37

5.4

7.5

81.16

83.37

u/l

2.39

6645

54047

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

5.38

5.36

1.1

1.75

0.85

—

(40765096) Chromosome analysis panel by Banding

239

0.24

5.33

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

851

0.53

5.32

1.5

1.3

—

(3011985) Renin [Units/volume] in Plasma

860

0.53

5.28

1.1

1.3

49.26

53.96

mu/l

0.11

749

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

891

0.54

5.26

1.9

2.1

74.61

985.54

u/ml

1.57

875

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1305

0.62

5.25

1.2

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

802

7758

0.84

5.17

3.1

3.9

1.23

mmol/l

0.84

634

6697

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

113

1440

0.64

5.16

1.2

1.3

—

(3042936) Bacteria identified in Isolate by Culture

1266

11815

0.87

5.14

1.8

1.9

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

332

3524

0.77

5.13

2.7

2.8

3.98

2.86

ratio

0.41

253

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

110

1408

0.64

5.13

1.6

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

293

3159

0.76

5.10

4.7

5.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

263

2878

0.75

5.09

1.1

75.35

129.12

iu/ml

1.83

938

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

155

1849

0.69

5.09

1.9

2.1

3.72

3.65

g/l

0.20

140

1739

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

432

0.36

5.07

1.2

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

718

0.50

5.06

1.2

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

718

0.50

5.06

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

718

0.50

5.06

1.2

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

533

5344

0.81

5.04

2.5

2.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7526

64026

0.92

4.99

6.2

7.0

41.77

41.47

mmol/mol

1.58

6581

57141

(3045142) Bone marrow Pathology biopsy report

916

0.56

4.95

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

119

1484

0.66

4.92

1.3

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

232

2569

0.74

4.88

1.8

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

171

1988

0.70

4.88

1.3

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

815

0.54

4.84

1.1

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

160

1874

0.70

4.77

1.3

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

143

1708

0.69

4.75

1.8

2.0

90.14

87.20

0.92

130

1628

(40768800) Prostate Pathology biopsy report

155

1820

0.70

4.69

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

963

0.59

4.67

1.1

—

(40758558) Short blood count panel - Blood

2424

18378

1.11

4.63

5.0

6.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

134

1606

0.68

4.56

2.4

2.1

203.53

214.72

0.80

120

1505

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

230

1.90

4.55

1.0

—

(3008898) HLA-B27 [Presence]

913

0.58

4.53

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

430

0.40

4.48

1.1

1.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

321

1.75

4.48

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

220

1.91

4.46

1.3

1.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1448

13274

0.88

4.46

2.1

2.6

19.86

20.69

1.47

1095

11091

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

1063

0.62

4.46

1.4

1.5

73.36

64.27

1.80

663

(3009343) pH of Capillary blood

627

6113

0.84

4.45

2.8

3.8

7.43

7.42

2.00

814

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

331

0.32

4.43

1.0

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

331

0.32

4.43

1.0

1.6

—

(40768441) Liver Pathology biopsy report

416

0.39

4.43

1.0

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

894

0.59

4.38

1.3

1.2

—

15.92

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

240

1.86

4.33

2.5

2.0

65.05

51.41

umol/l

1.90

190

(3048689) Calprotectin [Mass/mass] in Stool

648

6276

0.84

4.27

1.7

1.8

144.94

176.95

ug/g

1.79

481

4757

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

825

0.58

4.26

1.4

1.5

14.74

26.70

4.40

515

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

626

4357

1.19

4.21

2.5

3.6

24.05

24.13

mmol/l

0.24

592

4208

(3022313) Gas panel - Capillary blood

429

4313

0.81

4.21

2.9

3.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

905

0.60

4.21

1.3

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

639

6187

0.84

4.20

2.8

3.8

5.16

kpa

0.02

567

5778

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1037

0.62

4.20

1.2

83.28

49.33

u/ml

—

121

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

798

0.58

4.15

1.1

1.2

216.90

268.02

pmol/l

1.54

660

(3048929) Epstein Barr virus Ab [Presence] in Serum

932

0.61

4.15

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1192

0.65

4.12

1.2

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1192

0.65

4.12

1.2

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

722

0.56

4.11

1.1

135.93

429.20

iu/ml

—

111

(21494755) Public health laboratory ask at order entry panel

657

0.54

4.09

1.3

1.4

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1537

13970

0.89

4.09

2.0

2.5

2.17

2.24

g/l

4.82

1333

12674

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

762

0.57

4.07

1.0

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1117

8155

1.14

4.07

3.7

5.4

1.53

1.39

mmol/l

3.52

1079

7858

(1616796) Gas panel - Central venous blood

215

2330

0.76

3.97

3.0

3.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

115

1378

0.68

3.96

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

126

1483

0.70

3.94

1.4

1.3

35.18

40.81

u/l

0.31

103

1260

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

539

0.50

3.90

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

845

0.60

3.89

1.4

1.6

0.55

0.84

g/l

1.89

636

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

612

5906

0.85

3.89

2.8

3.7

1.95

2.10

mmol/l

0.42

434

4329

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

296

0.33

3.89

1.0

1.1

—

(40757373) Influenza virus identified in Isolate

190

1.91

3.88

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1066

0.65

3.87

1.7

1.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

146

1670

0.72

3.87

2.6

—

(3011412) CD3 cells [#/volume] in Blood

524

0.50

3.82

2.6

1.8

1.11

1.04

e9/l

0.22

481

(3009214) Lutropin [Units/volume] in Serum or Plasma

642

0.55

3.81

1.3

13.63

13.40

u/l

0.03

500

(3023183) Ammonium ion [Moles/volume] in Plasma

245

1557

1.30

3.80

1.5

2.0

26.11

32.53

umol/l

4.36

195

1331

(3020876) Protein [Mass/time] in 24 hour Urine

1081

0.65

3.80

2.0

2.2

0.88

1.03

g/24h

0.18

514

(3021901) Oxygen saturation in Capillary blood

192

2097

0.75

3.77

2.4

2.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

218

2339

0.76

3.77

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1526

13810

0.90

3.75

2.0

2.6

0.82

0.81

mmol/l

0.41

1310

12585

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2169

19280

0.91

3.73

2.2

2.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

976

0.64

3.72

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

211

2265

0.76

3.67

1.9

2.2

78.47

98.47

ug/min

0.38

110

1270

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

335

0.39

3.67

1.1

1.6

—

(3017732) Neutrophils [#/volume] in Blood

474

4646

0.83

3.63

3.4

3.3

5.68

5.79

e9/l

0.04

318

3297

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

237

1.78

3.61

1.3

1.5

93.63

92.49

umol/l

0.02

140

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1768

15848

0.90

3.61

1.6

1.7

1.85

1.60

mg/l

1.46

1356

12475

(21494434) Karyotype in Bone marrow

814

0.62

3.55

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1034

0.66

3.54

4.0

3.7

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.33

3.51

2.2

2.3

143.11

135.46

nmol/l

0.19

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

304

0.38

3.50

1.9

2.2

—

(3045424) Erythrocytes [Presence] in Urine

104

1237

0.69

3.49

1.6

1.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

5553

44012

1.07

3.49

20.7

22.0

1.40

1.44

inr

1.30

1139

12288

(3035637) Corticotropin [Mass/volume] in Plasma

738

0.60

3.48

1.0

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

778

7302

0.87

3.47

2.2

2.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

706

0.59

3.46

1.0

1.1

254.38

305.03

u/ml

0.64

408

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

775

0.61

3.41

1.4

1.2

117.94

119.51

u/ml

0.05

178

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

805

0.62

3.40

1.4

1.3

—

nmol/l

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

366

3647

0.82

3.36

2.0

1.9

10.06

10.28

nmol/l

0.18

298

3022

(3020630) Protein [Mass/volume] in Serum or Plasma

939

8685

0.88

3.36

2.1

2.4

65.51

65.71

g/l

0.32

775

7649

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

356

0.44

3.35

1.0

280.86

294.70

mg/l

0.36

308

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

324

3266

0.81

3.34

2.3

2.9

405.23

2832.02

u/ml

1.96

258

2774

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

106

1244

0.70

3.33

1.2

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

814

0.64

3.22

1.9

—

0.44

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

405

0.49

3.20

1.1

1.4

2.50

3.40

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1079

0.68

3.19

1.1

1.3

—

(40767503) Oxygen content in Capillary blood by calculation

206

2170

0.78

3.15

2.5

2.6

16.40

15.53

2.19

1169

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1076

0.69

3.15

1.1

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

330

1.60

3.15

1.2

1.3

—

(3027315) Oxygen [Partial pressure] in Blood

216

2261

0.78

3.14

3.7

4.5

7.86

8.25

kpa

3.57

207

2186

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1075

0.69

3.14

1.1

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

738

0.62

3.14

1.1

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

665

0.61

3.11

1.2

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

553

5274

0.86

3.10

2.6

3.4

25.21

25.12

mmol/l

0.27

532

5129

(3004451) EKG impression Narrative

571

0.58

3.09

1.1

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

332

1.59

3.08

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1088

0.69

3.05

1.1

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1076

0.69

3.02

1.1

1.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7854

66185

0.94

2.99

4.6

5.4

6.16

6.14

mmol/l

0.49

6766

57769

(3003434) Protein [Mass/volume] in Pleural fluid

172

1838

0.77

2.97

1.4

1.5

30.40

30.70

g/l

0.12

150

1623

(3013290) Carbon dioxide [Partial pressure] in Blood

217

2250

0.79

2.94

3.7

4.5

5.04

5.02

kpa

0.14

209

2175

(3004775) Volume in Urine collected for unspecified duration

805

0.65

2.93

2.1

672.40

652.15

0.15

498

(3028717) Thiamine [Mass/volume] in Blood

2.59

2.93

1.1

1.2

—

(3006462) Nitrate [Presence] in Urine

424

0.52

2.92

3.4

4.3

—

(3012501) Base excess in Blood by calculation

217

2248

0.79

2.92

3.7

4.4

2.80

2.85

mmol/l

0.08

152

1550

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

423

0.52

2.90

1.0

1.1

43.55

29.76

u/l

0.36

365

(21494814) CD8 cells/100 lymphocytes in Specimen

230

0.36

2.89

4.0

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1105

0.71

2.89

1.1

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

321

0.46

2.84

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

514

0.58

2.82

2.0

2.2

26.80

94.93

ug/min

—

121

(3020191) Ethanol [Moles/volume] in Serum or Plasma

327

1.56

2.81

1.2

0.76

0.99

promille

0.66

236

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1797

15904

0.92

2.77

3.0

3.5

0.88

ug/l

0.06

1307

11778

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

100

1141

0.72

2.73

2.5

3.6

29.89

45.44

u/ml

1.21

1107

(3015235) Bicarbonate [Moles/volume] in Capillary blood

272

2727

0.82

2.73

2.4

3.1

24.97

25.02

mmol/l

0.07

263

2665

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

141

0.29

2.71

1.0

1.1

—

(4062490) Immunoglobulin typing, IgG

528

0.59

2.70

1.1

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

121

1337

0.74

2.69

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

759

0.66

2.68

1.1

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

156

987

1.31

2.62

3.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

139

868

1.32

2.57

1.4

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

162

0.36

2.56

1.0

1.3

166.70

144.99

pmol/l

—

162

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

166

1742

0.78

2.54

1.4

1.5

31.26

5.37

iu/ml

0.70

458

(3000850) Epithelial cells [#/volume] in Urine

2453

19073

1.07

2.53

2.7

2.8

5.62

5.01

e6/l

1.54

2177

17035

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

371

0.53

2.52

1.0

1.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1358

12113

0.91

2.51

1.2

1.77

1.70

u/ml

0.06

277

2840

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

537

0.61

2.50

1.0

1.1

118.87

114.16

0.59

456

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

717

0.66

2.50

1.2

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

557

0.62

2.49

1.3

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

556

0.62

2.48

1.3

1.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

525

0.61

2.47

1.1

1.3

6.31

7.15

g/l

0.93

367

(3024139) IgG subclass 3 [Mass/volume] in Serum

525

0.61

2.47

1.1

1.3

0.48

0.47

g/l

0.04

373

(3028192) IgG subclass 2 [Mass/volume] in Serum

525

0.61

2.47

1.1

1.3

2.89

2.85

g/l

0.06

373

(3021879) Hepatitis B virus core Ab [Presence] in Serum

288

2840

0.83

2.47

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

258

0.45

2.46

1.0

1.2

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

2.45

0.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.00

2.44

0.0

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2357

20542

0.93

2.44

2.5

3.0

35.42

38.09

u/l

0.80

2155

19153

(3000034) Microalbumin [Mass/volume] in Urine

808

0.69

2.40

2.7

3.1

36.79

33.24

mg/l

0.10

607

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

518

0.62

2.35

1.3

1.4

56.96

67.84

0.99

416

(3012565) Volume of 24 hour Urine

371

0.55

2.31

2.1

2.3

1529.44

1769.10

0.55

311

(3024354) Oxygen [Partial pressure] in Venous blood

1032

7772

1.10

2.29

2.3

3.1

4.12

4.34

kpa

3.25

972

7474

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

604

0.65

2.28

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

272

0.48

2.28

1.5

1.9

—

(3037121) Protein [Mass/volume] in Urine

322

3118

0.85

2.27

2.4

2.7

0.29

0.31

g/l

0.20

104

1180

(3002079) Sodium [Moles/time] in 24 hour Urine

238

0.45

2.27

1.3

1.1

108.54

144.10

mmol/24h

1.45

238

(3002385) Erythrocyte distribution width [Ratio]

6946

55876

1.06

2.26

23.7

22.8

15.11

15.65

13.44

6756

54653

(3010838) Calcium [Moles/time] in 24 hour Urine

107

1167

0.75

2.24

1.6

1.7

4.15

4.35

mmol/24h

0.25

956

(3022948) Iron [Moles/volume] in Serum or Plasma

1706

14999

0.93

2.24

2.0

2.5

10.88

11.48

umol/l

3.07

1479

13684

(3008116) Ketones [Moles/volume] in Urine by Test strip

152

1.74

2.22

1.2

1.3

—

(3021788) Differential panel - Synovial fluid

147

1535

0.79

2.21

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

851

0.71

2.19

1.1

1.2

54.38

60.60

u/l

0.61

763

(3051651) Icteric interference index of Serum or Plasma

520

1.38

2.19

3.4

3.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

200

0.41

2.19

3.2

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

210

0.43

2.15

3.7

1.7

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

375

3563

0.86

2.10

3.2

4.3

24.99

24.90

mmol/l

0.23

314

3178

(3045414) Leukocytes [Presence] in Urine

354

3377

0.86

2.10

2.2

2.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

462

0.62

2.09

2.0

1.8

91.74

102.35

umol/l

0.97

462

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

2.09

0.0

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

451

0.62

2.08

1.4

3.91

2.58

0.33

372

(3035320) C reactive protein [Mass/volume] in Body fluid

569

0.66

2.05

3.0

2.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

136

0.36

2.03

1.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

112

706

1.31

2.02

1.2

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3803

30176

1.06

2.00

2.6

3.0

136.83

157.99

ug/l

5.91

3306

26776

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

189

1.61

2.00

1.1

—

(4146454) Self-monitoring of blood glucose

1006

0.75

2.00

2.6

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

115

1220

0.77

2.00

1.3

458.30

387.65

u/l

0.21

101

1150

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

395

0.60

1.99

2.8

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

110

1172

0.77

1.98

1.3

1.4

6.54

6.42

mmol/l

0.18

1094

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

505

0.65

1.98

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

465

0.64

1.98

1.1

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

1.94

1.97

1.1

—

(40768446) Kidney Pathology biopsy report

168

0.44

1.97

1.0

1.4

—

(3016750) Collection duration of Urine

554

0.67

1.97

2.2

1.9

494.73

500.46

min

0.11

379

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

111

1180

0.77

1.97

1.2

1.3

0.83

0.79

nmol/l

0.17

950

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

519

4797

0.89

1.95

5.3

7.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

696

1.30

1.94

1.2

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1275

9772

1.08

1.94

3.1

3.2

247.02

290.30

ng/l

2.75

1165

8971

(44813793) Dust mix specific IgE antibody measurement

298

0.55

1.93

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

318

0.57

1.91

2.1

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

114

1202

0.78

1.90

1.3

1.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

1.90

0.0

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

135

1.71

1.89

1.1

1.3

89.88

104.48

ug/l

0.25

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

166

0.45

1.85

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

166

0.45

1.85

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

166

0.45

1.85

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

166

0.45

1.85

1.1

—

(3036603) Volume of Urine

506

0.67

1.84

1.9

1.4

1484.80

1737.07

1.80

480

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

335

0.59

1.84

1.9

1.8

616.47

488.60

e6/l

0.56

289

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

632

0.70

1.83

1.1

1.2

1.45

4.32

u/ml

2.70

194

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

124

1.73

1.83

2.3

2.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

494

3624

1.13

1.82

2.2

2.5

31.95

22.45

au/ml

0.56

149

(3041096) Erythrocytes [Presence] in Urine by Automated

2166

18751

0.94

1.81

4.2

4.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

425

0.64

1.81

1.0

—

(3040151) Glucose [Moles/volume] in Capillary blood

180

1220

1.22

1.80

9.1

9.3

7.45

7.37

mmol/l

0.11

138

996

(3051387) C reactive protein [Mass/volume] in Capillary blood

278

1962

1.17

1.79

4.0

30.58

30.88

mg/l

0.04

203

1334

(3014148) Varicella zoster virus Ab [Titer] in Serum

301

0.57

1.79

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

762

0.73

1.78

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

714

0.73

1.77

1.1

—

u/ml

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

128

0.39

1.77

12.5

12.7

5.80

5.46

mmol/l

—

128

(3016038) Potassium [Moles/volume] in Urine

104

665

1.29

1.73

1.1

34.92

34.71

mmol/l

0.03

553

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

992

0.77

1.73

1.3

1.5

—

(3024928) Oxygen saturation in Venous blood

260

1831

1.17

1.73

1.6

2.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

566

0.70

1.72

1.0

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

1.71

0.0

7.1

—

0.97

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

672

6071

0.91

1.70

2.4

3.2

126.55

125.22

g/l

0.91

654

5924

(3032057) Clostridioides difficile [Presence] in Stool

252

1.47

1.68

1.6

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

838

0.76

1.67

1.2

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

181

1786

0.83

1.67

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

511

1.32

1.66

2.7

2.1

1.55

2.56

u/field

1.20

333

(3051593) INR in Capillary blood by Coagulation assay

686

0.73

1.66

8.0

12.8

—

(3017569) Oxygen content in Arterial blood

523

0.69

1.66

1.9

2.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

141

1.64

1.65

1.2

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

449

4136

0.89

1.64

3.5

4.5

0.92

0.86

2.75

425

3889

(3048879) Bone marrow aspiration report

324

0.61

1.64

1.1

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

423

0.66

1.62

1.1

98.08

89.57

1.47

380

(3014891) Appearance of Pleural fluid

221

1.49

1.60

1.3

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

310

0.61

1.58

2.1

2.5

45.75

36.64

2.06

193

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

456

4183

0.89

1.57

3.6

4.4

1.61

1.54

1.32

433

3940

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

124

1.66

1.56

2.3

2.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

448

0.68

1.55

4.8

4.7

85.36

141.30

u/ml

—

128

(3008152) Bicarbonate [Moles/volume] in Arterial blood

814

6188

1.09

1.55

4.8

6.2

24.48

24.55

mmol/l

0.23

781

5870

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

575

5207

0.90

1.55

1.5

1.6

1.61

1.55

g/l

0.76

445

4414

(3023199) Leukocytes [#/volume] in Pleural fluid

161

1592

0.83

1.55

1.4

1.5

4031.71

1942.87

e6/l

0.72

111

1152

(40758358) Immune stain study

0.00

1.54

0.0

1.0

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

387

0.66

1.52

2.0

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

806

0.76

1.52

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

522

0.71

1.50

1.1

1.0

—

(3008295) Osmolality of Serum or Plasma

124

827

1.24

1.50

1.3

275.60

274.56

mosm/kgh2o

0.16

590

(3010421) pH of Blood

270

2552

0.87

1.50

3.4

4.3

7.42

0.49

224

2314

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.88

1.50

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

169

0.49

1.49

1.4

54.00

204.24

nmol/24h

—

169

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

335

0.64

1.49

1.3

1.1

0.30

0.74

u/ml

2.19

159

(3023520) Reticulocytes [#/volume] in Blood

1051

9253

0.93

1.48

2.2

2.4

64.88

67.15

e9/l

1.31

760

7080

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.39

1.46

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

846

0.78

1.45

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

603

0.74

1.44

1.1

1.2

5.52

4.30

u/ml

0.26

264

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

743

0.76

1.43

1.2

—

(40768806) Pleura Pathology biopsy report

139

1381

0.83

1.43

1.4

1.6

—

(3044927) Protein electrophoresis panel - Urine

116

1173

0.81

1.43

1.3

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

103

1054

0.80

1.42

3.2

3.5

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1761

13811

1.06

1.41

1.6

1.9

29.73

30.25

2.66

1690

13386

(3020650) Glucose [Presence] in Urine

149

0.50

1.41

2.9

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

195

1.48

1.38

1.1

1.02

1.16

u/l

1.92

103

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

368

0.67

1.38

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

116

1.63

1.38

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

6611

53467

1.04

1.37

3.7

4.4

15.94

16.12

mm/h

0.32

5836

48288

(3008536) Aspergillus sp Ab [Presence] in Serum

134

0.49

1.37

1.9

1.4

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

367

0.67

1.36

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

367

0.67

1.36

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

163

0.50

1.36

1.0

0.04

0.96

u/ml

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

110

734

1.24

1.36

1.3

292.22

340.39

titre

0.13

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.35

0.0

12.8

—

212.48

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

1.33

0.0

1.4

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

365

0.68

1.33

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

364

0.68

1.32

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

364

0.68

1.32

1.1

—

(3012441) Differential panel - Pleural fluid

140

1376

0.84

1.31

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

559

5019

0.91

1.31

5.0

7.0

24.18

24.41

mmol/l

0.85

513

4739

(3036180) Methadone [Presence] in Urine

2.12

1.30

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

146

0.51

1.29

2.8

2.5

—

(3035880) pH of Pleural fluid

721

0.78

1.29

1.2

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

868

0.80

1.29

1.3

1.4

14.22

13.74

u/l

0.30

828

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

111

1113

0.82

1.29

1.5

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

296

1.36

1.27

2.0

2.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

296

1.36

1.27

2.1

2.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

159

0.52

1.27

4.0

2.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

271

0.64

1.25

2.7

2.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

150

1457

0.85

1.24

1.4

1.5

27329.99

66572.69

e6/l

3.26

866

(3019420) Tryptase [Mass/volume] in Serum or Plasma

220

0.60

1.24

1.6

1.5

8.04

10.77

ug/l

0.69

196

(3018405) Lactate [Moles/volume] in Arterial blood

461

3457

1.10

1.24

3.0

3.7

1.46

1.43

mmol/l

0.19

453

3384

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.88

1.23

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.88

1.23

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.88

1.23

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

118

0.49

1.22

4.6

8.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

218

2051

0.87

1.20

1.6

26782.65

14710.95

e6/l

1.31

153

1465

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

197

0.58

1.19

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

461

0.73

1.19

3.3

3.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

130

897

1.20

1.19

1.8

1.6

29.74

25.98

u/ml

0.47

188

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

257

0.64

1.18

1.2

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

344

0.69

1.16

5.6

5.7

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

496

0.75

1.16

1.1

1.2

88.57

132.34

titre

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

285

0.66

1.15

2.0

1.9

1107.61

1594.41

u/ml

0.73

274

(3010370) Gastrin [Moles/volume] in Serum or Plasma

0.45

1.14

1.4

1.5

48.40

50.15

pmol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

274

0.66

1.13

1.0

0.21

1.30

u/ml

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8706

70918

1.04

1.12

9.3

11.5

21.90

23.09

u/l

2.58

8113

67291

(3010144) Erythrocytes [#/volume] in Synovial fluid

824

0.81

1.12

1.2

1.4

206692.04

189809.82

e6/l

0.06

572

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

203

0.61

1.11

1.5

1.3

26.75

30.60

umol/l

1.39

195

(3003888) Timothy IgE Ab [Units/volume] in Serum

282

0.67

1.10

1.0

1.27

1.71

u/ml

—

107

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

958

0.82

1.10

1.2

1.3

25.72

11.95

u/l

1.54

873

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

500

0.76

1.09

1.5

6.03

6.60

u/l

0.08

398

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.79

1.08

1.1

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

101

0.49

1.06

2.5

1.2

53.42

40.35

mg/l

—

(3044889) 12 lead EKG panel

6227

50468

1.03

1.04

4.5

4.7

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

104

714

1.20

1.04

1.3

46.25

58.20

titre

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

160

1.44

1.03

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

147

0.56

1.02

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

147

0.56

1.02

4.8

8.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.46

1.02

1.0

2.5

—

(3019225) pH of Specimen

1071

9286

0.95

1.01

4.0

4.5

—

(3014051) Protein [Presence] in Urine by Test strip

235

2169

0.89

1.00

2.6

3.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

285

0.69

1.00

1.4

1.8

682.25

5795.72

e6/l

0.94

197

(3045788) Cell count panel - Pleural fluid

126

1213

0.85

0.99

1.5

—

(3034426) Prothrombin time (PT)

132

0.56

0.99

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

216

0.65

0.99

1.4

11.63

15.23

g/l

0.83

170

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.98

0.0

2.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

145

0.57

0.98

1.0

1.3

1.59

1.54

g/l

—

145

(3039000) Anion gap in Blood

267

1976

1.12

0.98

4.2

5.9

11.27

11.33

mmol/l

0.11

247

1759

(3018572) Chloride [Moles/volume] in Blood

267

1976

1.12

0.98

4.2

5.9

104.62

104.84

mmol/l

0.29

247

1759

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

464

4134

0.92

0.97

1.9

2.2

3.84

3.69

g/l

1.03

372

3609

(3022229) Phosphate [Moles/volume] in Urine

0.00

0.97

0.0

1.1

—

16.03

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

509

0.78

0.97

1.3

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

293

0.70

0.97

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

392

1.26

0.96

1.1

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

234

0.67

0.96

1.1

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

762

0.82

0.95

1.2

1.3

—

(21491868) Cryoglobulin [Mass/volume] in Serum

233

0.67

0.94

1.2

—

0.41

g/l

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

761

0.82

0.94

1.2

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

120

0.55

0.94

1.0

1.2

—

13.53

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1553

12288

1.05

0.94

2.0

2.3

1.72

1.77

1.05

1244

10617

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

203

0.65

0.93

1.3

47.33

39.88

u/l

0.28

159

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

583

5137

0.93

4.0

5.8

24.79

24.86

mmol/l

0.15

576

5063

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.73

0.93

1.1

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

256

1.32

0.93

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

271

2467

0.90

0.92

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

252

1869

1.11

0.91

1.3

63.33

60.78

mmol/l

0.51

203

1493

(3013293) Extractable nuclear Ab [Presence] in Serum

0.49

0.90

1.0

1.5

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.48

0.90

1.4

1.1

—

(3028433) Virus identified in Specimen by Culture

230

0.68

0.89

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

220

0.67

0.89

1.4

1.5

7.60

7.68

—

109

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

108

0.53

0.88

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

547

0.80

0.88

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

501

0.79

0.88

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

501

0.79

0.88

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

315

0.73

0.88

1.0

—

(3049717) Cytology report of Urine Cyto stain

489

4322

0.93

0.87

2.7

2.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

468

4142

0.93

0.86

1.9

2.2

—

(3051101) Glucose [Moles/volume] in Cord blood

218

0.68

0.86

6.3

5.8

—

(3000764) Benzodiazepines [Presence] in Urine

139

1.42

0.85

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

167

1.38

0.85

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

469

4147

0.93

0.85

1.9

2.2

7.67

7.55

g/l

0.73

374

3617

(3052851) Hemolysis interference index of Serum or Plasma

372

2825

1.09

0.84

3.4

3.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

106

1017

0.86

0.84

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.78

0.84

1.4

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.53

0.84

1.3

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

312

0.74

0.84

1.1

1.2

40.66

40.29

g/l

0.07

152

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

506

0.80

0.83

1.5

1.7

176.40

189.65

pmol/l

0.58

449

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

110

779

1.16

0.82

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

659

5751

0.94

0.82

5.0

7.1

92.93

93.64

1.38

654

5723

(3047007) Chlamydophila sp Ab [Presence] in Serum

504

0.80

0.81

1.3

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

431

3814

0.93

0.81

2.0

2.6

0.37

0.35

u/ml

0.57

234

2180

(3027008) Opiates [Presence] in Urine

141

1.40

0.80

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.80

0.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

1.51

0.80

1.4

1.7

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

328

0.75

0.80

1.4

4.92

6.19

u/l

1.26

265

(3041918) Cholesterol [Moles/volume] in Pleural fluid

214

0.69

0.79

1.2

1.65

1.43

mmol/l

0.29

126

(3033923) Metanephrine [Moles/time] in 24 hour Urine

175

0.66

0.79

1.1

0.47

0.66

umol/24h

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

170

1.36

0.78

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

246

2226

0.91

0.78

1.1

538.33

221.21

titre

—

(3020874) Milk IgE Ab [Units/volume] in Serum

104

0.55

0.78

1.0

1.1

—

1.00

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

492

0.80

0.78

1.1

1.2

91.68

94.61

u/l

0.06

429

(3016879) Cocaine [Presence] in Urine

135

1.40

0.78

1.1

—

(3028300) Cannabinoids [Presence] in Urine

142

1.39

0.78

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

288

0.74

0.76

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

288

0.74

0.76

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.56

0.76

1.0

1.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4971

41589

0.97

0.76

3.9

5.7

12.72

12.54

umol/l

0.34

4530

39258

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

259

0.73

0.75

1.4

1.7

2776.80

18979.74

e6/l

—

149

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

229

2073

0.91

0.74

1.8

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

130

941

1.14

0.74

2.5

2.4

2.46

2.27

u/field

0.15

300

(3022621) pH of Urine by Test strip

706

5516

1.06

0.74

3.8

3.7

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

442

3887

0.93

0.72

1.9

2.2

10.52

10.37

g/l

0.24

346

3320

(3016650) Hepatitis A virus Ab [Presence] in Serum

780

0.85

0.71

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

239

1.28

0.70

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

121

0.61

0.70

1.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

555

4838

0.94

0.70

3.1

4.3

45.50

46.06

0.23

545

4784

(3005011) Chlamydia sp Ab [Titer] in Serum

1.57

0.68

2.2

1.9

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

0.54

0.67

1.0

1.1

—

0.42

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

327

0.78

0.67

1.2

1.4

61.48

35.83

iu/l

2.14

274

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

419

3236

1.07

0.66

1.2

1.3

49.69

60.98

au/ml

0.41

179

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

138

0.66

0.65

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

102

958

0.88

0.65

1.5

1.6

2.76

3.39

mg/l

0.28

746

(3034274) Bile acid [Moles/volume] in Serum --fasting

270

0.76

0.64

1.5

1.2

5.15

13.78

umol/l

2.33

181

(3003327) Ova and parasites identified in Stool by Light microscopy

181

1641

0.91

0.64

1.5

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

137

0.66

0.64

1.4

1.6

8.02

9.52

ug/l

1.05

137

(3037756) Immunofixation for Serum or Plasma

264

2352

0.92

0.63

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

177

1.30

0.63

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.57

0.62

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

184

0.72

0.62

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

193

0.73

0.61

1.2

2.70

8.02

u/l

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

154

1144

1.11

0.61

1.8

1.6

—

(3026782) Osmolality of Urine

2332

18765

1.03

0.61

3.0

3.2

558.82

531.71

mosm/kgh2o

8.81

1916

16061

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.61

0.0

1.1

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.61

0.0

6.9

—

42.63

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.61

0.0

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.61

0.0

1.1

—

0.01

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

172

1.29

0.59

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

554

0.85

0.59

1.1

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1058

8407

1.04

0.59

2.1

2.5

10.02

9.92

umol/l

0.04

853

7255

(3044242) Glucose [Moles/volume] in Arterial blood

504

1.16

0.57

1.5

1.9

—

(3020393) Adenovirus Ag [Presence] in Stool

1.47

0.57

1.1

1.0

—

(3026470) Cobalt [Mass/volume] in Blood

656

0.87

0.55

1.8

3.12

4.12

ug/l

0.60

595

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

876

7491

0.96

0.55

1.6

1.9

0.20

0.19

g/l

0.55

754

6835

(3027456) Digoxin [Moles/volume] in Serum or Plasma

403

3134

1.06

0.55

3.6

3.3

0.78

0.82

nmol/l

1.29

313

2432

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

379

0.83

0.53

2.9

2.8

206.13

220.19

u/l

0.64

374

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

150

0.71

0.53

1.2

35.57

289.40

u/l

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

437

3795

0.95

0.53

2.0

2.2

3.06

3.02

g/l

0.33

342

3266

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.53

0.52

1.7

1.3

1.60

1.03

u/field

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

503

4349

0.95

0.52

1.8

3.26

2.32

ug/l

0.45

375

3710

(3011648) Oxygen content in Venous blood

564

0.86

0.52

1.2

1.6

10.47

10.12

0.22

564

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

168

0.74

0.52

1.0

—

1.74

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

205

0.76

0.51

1.5

0.41

0.38

ug/l

—

109

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

475

0.85

0.51

1.1

1.2

32.92

29.61

u/l

0.14

405

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

177

0.74

0.51

1.3

1.2

—

(3020891) Body temperature

488

3830

1.05

0.50

3.5

4.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

658

0.88

0.50

1.5

1.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.65

0.49

2.0

1.8

1.81

0.66

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

591

5078

0.96

0.48

1.3

1.4

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.63

0.48

4.6

7.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

392

0.84

0.48

1.3

4.37

3.34

mmol/l

0.92

357

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

126

1140

0.91

0.47

4.8

5.7

13.04

12.71

mg/l

0.32

105

1017

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

229

0.79

0.47

1.6

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

715

0.89

0.46

1.5

1.4

—

(3017704) Immunofixation for Urine

584

0.87

0.46

1.5

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2713

22727

0.98

0.46

4.4

5.0

21.93

22.59

1.46

1352

12678

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.60

0.46

7.6

4.6

30.60

63.27

ug/min

—

(3003396) Base excess in Arterial blood by calculation

1384

11110

1.03

0.46

4.2

5.7

1.11

1.21

mmol/l

0.39

1049

8627

(3001729) Color of Synovial fluid

0.67

0.46

2.0

1.8

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

173

1.24

0.44

1.1

1.2

113.94

136.01

nmol/l

0.36

129

(3027944) Amphetamines [Presence] in Urine

136

1.27

0.43

1.1

—

(3036489) Thrombin time

275

2401

0.94

0.43

1.6

1.8

21.34

22.09

0.59

252

2182

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

475

0.87

0.43

1.1

3.71

4.33

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

122

1098

0.91

0.43

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.43

0.42

1.1

1.2

—

(40762814) Titanium [Mass/volume] in Blood

180

0.78

0.42

2.2

2.0

2.85

3.27

ug/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

189

0.78

0.42

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.41

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.41

0.0

14.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

376

0.85

0.41

1.3

643.86

273.07

ug/l

0.28

201

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

170

0.77

0.41

1.3

1.1

262.80

286.73

pmol/l

—

114

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

133

0.74

0.41

1.1

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.40

0.0

1.1

—

8.20

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.40

0.0

7.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.40

0.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

541

0.88

0.40

2.5

1.8

351.21

331.30

mu/l

0.15

492

(40761539) Cells [Type] in Urine sediment by Light microscopy

241

0.82

0.39

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

549

0.88

0.39

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2969

24797

0.98

0.39

2.2

2.5

59.04

63.76

u/l

0.76

2688

22655

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

352

1.15

0.38

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

154

1362

0.93

0.37

1.5

1.6

3.06

4.33

iu/l

1.59

381

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

293

0.84

0.37

1.4

13.64

21.57

1.03

237

(3022493) Free Hemoglobin [Mass/volume] in Plasma

372

0.86

0.37

1.0

2.8

59.13

66.89

mg/l

0.47

242

(3002619) Bacteria identified in Specimen by Culture

176

0.80

0.37

1.4

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1097

8816

1.03

0.36

4.5

6.4

119.89

118.36

g/l

1.80

1072

8560

(3020491) Glucose [Moles/volume] in Blood

553

0.89

0.35

1.9

2.4

6.89

7.34

mmol/l

0.86

374

(3025941) Bacteria identified in Stool by Culture

428

3666

0.96

0.35

1.3

—

(3000285) Sodium [Moles/volume] in Blood

147

0.78

0.34

1.5

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.34

0.34

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.68

0.33

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

524

0.90

0.33

1.8

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

128

0.77

0.33

1.1

1.2

—

(3002032) Base excess in Venous blood by calculation

1164

9383

1.02

0.32

2.5

3.6

2.02

1.95

mmol/l

0.24

956

7819

(3030981) Hyaline casts [#/volume] in Urine by Automated count

594

5045

0.97

0.32

3.1

2.9

0.39

0.32

e6/l

0.61

581

4955

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

250

1.15

0.31

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

158

1.20

0.31

1.0

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

172

0.81

0.31

1.4

134.63

132.36

ng/l

0.03

172

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3431

28561

0.99

0.31

4.7

5.8

7.60

5.05

ug/l

0.67

2926

24850

(3039443) Prostate specific Ag panel - Serum or Plasma

556

0.90

0.31

1.5

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4668

38121

1.01

0.31

2.8

3.1

49.58

57.31

u/l

6.11

4082

33934

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

365

0.88

0.30

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

198

0.83

0.30

1.1

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

286

0.86

0.30

1.4

73.37

61.32

1.57

246

(3027923) C peptide [Moles/volume] in Serum or Plasma

355

0.88

0.29

1.1

1.2

1.28

1.18

nmol/l

0.24

265

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

320

0.87

0.29

1.1

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

161

0.82

0.28

1.3

83.41

75.15

—

136

(3047181) Lactate [Moles/volume] in Blood

355

2819

1.04

0.28

4.0

5.3

1.41

1.36

mmol/l

0.33

324

2495

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

318

0.88

0.27

1.1

1.2

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

106

0.78

0.27

1.1

1.3

3.97

1.84

umol/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

124

0.80

0.27

1.1

1.2

15.67

17.23

u/l

—

(40757494) Bilirubin.total [Moles/volume] in Blood

473

0.90

0.27

1.6

2.1

19.57

25.03

umol/l

0.42

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

378

0.89

0.27

1.0

1.1

0.23

12.18

nmol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

550

0.91

0.27

1.2

1.03

1.48

nmol/l

4.56

493

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.69

0.26

1.0

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

489

0.91

0.26

1.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

489

0.91

0.26

1.0

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

208

1.15

0.26

1.3

1.5

17.10

16.55

pmol/l

0.22

159

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1163

9409

1.02

0.25

2.5

3.5

5.84

5.83

kpa

0.15

1103

9090

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.25

0.25

1.7

1.6

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

470

0.91

0.24

1.2

190.29

174.12

miu/ml

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1370

11109

1.02

0.24

4.2

5.7

4.91

5.05

kpa

6.21

1293

10441

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

227

0.87

0.23

1.5

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

689

5798

0.98

0.22

4.8

7.0

0.73

0.67

2.78

682

5746

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

692

5822

0.98

0.22

4.8

6.9

1.46

1.33

3.15

687

5769

(3027801) Oxygen [Partial pressure] in Arterial blood

1368

11103

1.02

0.22

4.2

5.7

11.55

11.64

kpa

0.25

1292

10429

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.21

0.22

1.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.21

0.0

1.1

—

54.73

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

163

1283

1.05

0.21

1.1

10.12

16.29

u/ml

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.21

0.0

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

602

0.93

0.21

1.0

1.1

—

17.53

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

120

0.82

0.21

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

155

0.85

0.21

1.2

0.78

1.90

mmol/l

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

3.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

8.5

—

55.60

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

0.20

—

(3033799) Differential panel - Peritoneal fluid

259

0.89

0.20

1.7

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

319

0.90

0.20

5.5

5.2

63.04

72.44

0.84

248

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.20

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.20

0.0

1.3

—

(3013762) Body weight Measured

0.00

0.20

0.0

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.20

0.0

1.0

—

(3025577) Chromium [Mass/volume] in Blood

634

0.93

0.20

1.9

1.88

2.21

ug/l

0.53

532

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

106

921

0.95

0.20

2.6

2.9

—

(3000991) Gas panel - Venous blood

931

7793

0.98

0.19

4.2

6.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.25

0.19

1.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.18

0.19

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

0.84

0.18

1.0

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

179

0.87

0.18

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.18

0.17

4.4

5.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

395

3180

1.02

0.16

1.9

2.1

36.37

36.70

g/l

0.45

296

2638

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

229

0.90

0.16

1.0

1.1

9.35

11.28

iu/ml

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

273

2310

0.97

0.16

1.3

1.4

257.61

261.41

ug/g

0.12

140

1430

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

433

0.93

0.16

1.4

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.78

0.15

1.5

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.78

0.15

1.0

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.78

0.15

1.3

1.2

8.50

12.71

u/l

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

714

5972

0.98

0.15

1.7

2.1

413.54

385.83

nmol/l

2.90

597

5351

(3019977) pH of Arterial blood

617

0.95

0.15

1.9

2.4

7.42

0.06

245

(3025018) Bordetella pertussis Ab [Titer] in Serum

193

0.90

0.15

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.09

0.15

12.4

12.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

139

1187

0.96

0.14

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

269

0.92

0.14

1.0

1.1

—

(3044007) Cell count panel - Peritoneal fluid

226

0.91

0.13

1.5

1.7

—

(3015183) Erythrocyte sedimentation rate

123

0.87

0.13

1.0

1.5

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

140

1.12

0.13

8.9

7.7

13.69

13.71

0.02

140

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

225

0.91

0.13

1.9

2.6

7.29

7.49

mmol/l

0.20

151

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

101

1.14

0.12

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.16

0.11

1.0

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

155

1312

0.97

0.11

2.0

2.2

35.70

28.89

mg/l

0.59

306

(4212803) Bone marrow aspirate examination

102

1.13

0.11

1.1

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

429

3480

1.02

0.11

2.4

3.1

4.29

4.27

pmol/l

0.14

351

2959

(3002523) Influenza virus A Ag [Presence] in Specimen

264

0.94

0.10

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

154

0.91

0.10

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.06

0.09

1.0

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

425

1.05

0.09

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.03

0.09

1.8

1.6

25.60

16.97

umol/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.03

0.09

1.2

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.12

0.09

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.14

0.08

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.05

0.08

1.3

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.03

0.08

1.2

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.78

0.08

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.07

0.08

1.0

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

413

3442

0.99

0.08

1.9

2.3

1.41

1.19

g/l

0.35

319

2839

(3016502) Oxygen saturation in Arterial blood

1207

9882

1.01

0.07

4.3

5.9

94.83

95.07

0.47

1159

9447

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.85

0.07

1.3

1.0

—

(3024263) Appearance of Synovial fluid

454

1.03

0.06

1.2

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

277

2310

0.99

0.06

2.1

2.3

127.36

124.56

g/l

1.08

209

1713

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.89

0.06

1.1

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

200

1671

0.99

0.06

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

125

0.92

0.06

1.1

1337.50

1787.44

miu/ml

0.78

125

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

339

2764

1.01

0.05

2.0

2.2

0.00

g/l

0.22

281

2472

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

108

0.91

0.05

1.3

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

0.90

0.05

1.1

1.3

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

208

0.95

0.05

1.2

1.3

21.24

28.96

0.69

135

(3019060) Gas panel - Arterial blood

819

6709

1.01

0.05

3.4

4.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

139

1.07

0.05

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

475

3884

1.01

0.05

1.9

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

174

0.95

0.04

1.1

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

107

1.08

0.04

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

332

2714

1.01

0.04

2.0

2.2

0.00

g/l

-0.00

280

2462

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1118

9238

1.00

0.03

4.3

4.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

686

0.98

0.03

1.1

1.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

893

7376

1.00

0.02

2.7

3.5

88.87

99.64

ng/l

3.29

717

6054

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.08

0.02

1.7

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

358

2963

0.99

0.02

2.0

2.2

0.02

0.05

g/l

1.94

298

2656

(3044941) Cell count panel - Synovial fluid

160

1307

1.01

0.02

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

196

0.97

0.02

1.3

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

1150

9488

1.00

0.02

1.7

1.9

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

328

0.98

0.01

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

328

0.98

0.01

2.2

2.8

—

(36660697) Celiac disease serology panel - Serum

515

4251

1.00

0.01

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

162

0.97

0.01

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

195

0.97

0.01

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

184

1.03

0.01

1.1

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

509

4199

1.00

0.00

1.9

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

252

0.98

0.00

1.1

1.2

—

(1002224) Polysomnography panel

118

977

0.99

0.00

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

113

1.02

0.00

1.6

44.43

47.43

umol/l

0.16

113

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

122

1.01

0.00

1.2

1.7

1.75

1.23

ug/l

0.32

113

(3029075) Extractable nuclear Ab panel - Serum

141

0.99

0.00

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

140

1.00

0.00

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.00

0.00

1.3

1.1

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.95

0.00

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

149

0.99

0.00

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

181

1.00

0.00

1.3

1.4

30.68

21.63

0.43

139

(3002331) Protein [Mass/volume] in Peritoneal fluid

182

1.00

0.00

1.3

27.34

59.61

g/l

0.53

148

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

124

1.00

0.00

1.0

1.2

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.80

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.44

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.4

—

1.50

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.4

—

6.40

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.95

-0.00

1.0

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.96

-0.00

1.2

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.6

—

1.76

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.92

-0.00

1.0

1.1

1.50

1.70

umol/24h

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3042517) Benzodiazepines panel - Urine

0.00

-0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

3.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

-0.00

0.0

2.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

2.18

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

17.33

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.00

-0.00

1.0

1.2

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

5.2

—

11.67

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

3.0

—

2.88

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.00

-0.00

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: G6_AD_STRICT – Alzheimer’s disease, strict definition

GWS hits: 30

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer’s disease, strict definition

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer’s disease, strict definition (G6_AD_STRICT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints